Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription Articles published in J Invest Dermatol Retrieve available abstracts of 421 articles: HTML format

Single Articles

June 2025
1. SCHNEIDER MR, Meier M
   Bringing High-Resolution Spatial Order to Sebaceous Glands.
   J Invest Dermatol. 2025 Jun 11:S0022-202X(25)00526.
   PubMed    
   
   
   
2. GROLLEAU C, Poisot T, Roux C, Perray L, et al
   Single-cell profiling of lichen planus reveals type I interferon response triggering the interface dermatitis reaction.
   J Invest Dermatol. 2025 Jun 9:S0022-202X(25)00555.
   PubMed     Abstract available
   
   
   
3. BECKER SL, Vague M, Ortega-Loayza AG
   Insights into the Pathogenesis of Pyoderma Gangrenosum.
   J Invest Dermatol. 2025;145:1305-1322.
   PubMed     Abstract available
   
   
   
4. WANG J, Ho M, Bunick CG
   Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors.
   J Invest Dermatol. 2025;145:1471-1488.
   PubMed     Abstract available
   
   
   
5. LI J, Li S, Zhang Q, Liang M, et al
   Apocrine Gland Damage and the Release of Specific Keratins in Early Stage Indicate the Crucial Involvement of Apocrine Glands in Hidradenitis Suppurativa.
   J Invest Dermatol. 2025;145:1371-1384.
   PubMed     Abstract available
   
   
   
6. FLORA A, Pham J, Woods JA, Radzeika M, et al
   The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial.
   J Invest Dermatol. 2025;145:1396-1406.
   PubMed     Abstract available
   
   
   
7. CHEN KL, Chiu YE, Vleugels RA, Co DO, et al
   Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies.
   J Invest Dermatol. 2025;145:1294-1304.
   PubMed     Abstract available
   
   
   
8. EL-HOWATI A, Edmans JG, Santocildes-Romero ME, Madsen LS, et al
   A Tissue-Engineered Model of T-Cell-Mediated Oral Mucosal Inflammatory Disease.
   J Invest Dermatol. 2025;145:1447-1458.
   PubMed     Abstract available
   
   
   May 2025
9. MANN C, Ojak G, Hyde I, Beczinski J, et al
   Epidermal IL-36 and CCL17 protein expression distinguish palmar eczema from palmar psoriasis.
   J Invest Dermatol. 2025 May 30:S0022-202X(25)00535.
   PubMed    
   
   
   
10. KENTLEY J, Kurtansky N, Jain M, Cordova M, et al
    Non-invasive diagnosis of melanoma using machine learning and reflectance confocal microscopy.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00539.
    PubMed    
    
    
    
11. HIERMAIER M, Egu DT, Sigmund AM, Ernst N, et al
    The Multi-kinase Inhibitor Midostaurin Mitigates Loss of Intercellular Adhesion and Skin Blistering in Pemphigus Vulgaris.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00538.
    PubMed     Abstract available
    
    
    
12. DUZ T, Torocsik D, Simmering A, Wolf P, et al
    High-Resolution Spatial Map of the Human Facial Sebaceous Gland Reveals Marker Genes and Decodes Sebocyte Differentiation.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00540.
    PubMed     Abstract available
    
    
    
13. OCHIAI S, Larson AR, Mayer JU, Yang J, et al
    Allergic Skin Inflammation Drives IL-4-Dependent Differentiation of Dermal CD11b-low Dendritic Cells.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00536.
    PubMed     Abstract available
    
    
    
14. KIM JY, Lee EJ, Jang G, Park S, et al
    Targeting IL-24 signaling to restore skin barrier function: Discovery of penta-O-galloyl-beta-D-glucose via in silico screening.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00537.
    PubMed    
    
    
    
15. FUNCH AB, Weber JF, Mraz V, Kongsbak-Wismann M, et al
    CD8(+) Skin-Resident Memory T Cells Require TCR Signaling for their Persistence in a Mouse Model of Allergic Contact Dermatitis.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00529.
    PubMed     Abstract available
    
    
    
16. KIM G, Siprashvili Z, Yang X, Meyers JM, et al
    In vivo CRISPRi screen reveals lncRNA portfolio crucial for cutaneous squamous cell carcinoma tumor growth.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00532.
    PubMed     Abstract available
    
    
    
17. BURKE OM, Ma F, Huang J, Kirsner RS, et al
    Melanoma Incidence and Survival: A SEER Database Study.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00527.
    PubMed    
    
    
    
18. AKBARIALIABAD H, Bunick CG
    Revisiting RORgammat Inhibition in Plaque Psoriasis: Lessons Learned from BI 730357.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00406.
    PubMed    
    
    
    
19. HAARMANN-STEMMANN T, Esser C
    Cutaneous Exposure to Per- and Polyfluoroalkyl Substances: Cause for Concern?
    J Invest Dermatol. 2025 May 26:S0022-202X(25)00397.
    PubMed    
    
    
    
20. BYRD AS, Moreau JM, Petukhova L, Frew J, et al
    Differentiating the Role of Inflammation in Hidradenitis Suppurativa from that in Other Inflammatory Skin Diseases.
    J Invest Dermatol. 2025 May 24:S0022-202X(25)00450.
    PubMed     Abstract available
    
    
    
21. CAMERA E, Di Nardo A
    A Microbial Shield: Interactions between UVR, cis-Urocanic Acid, and the Skin Microbiome.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00452.
    PubMed    
    
    
    
22. YURCHENKO AA, Sharkhith H, Rajabi F, Bogiatzi S, et al
    Integrative Molecular Analysis of Skin Tumors from CYLD Cutaneous Syndrome Patients.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00496.
    PubMed     Abstract available
    
    
    
23. MOLLER LBP, Kromann B, Kabatnik S, Hjortlund JH, et al
    Spatial Proteomic Profiling Reveals Increased Levels of Cholesterol Synthesis Proteins in Psoriasis Vulgaris.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00489.
    PubMed     Abstract available
    
    
    
24. PERES J, Damerell V, Chauhan J, Popovic A, et al
    Corrigendum to 'TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF' Journal of Investigative Dermatology, Volume 141, Issue 9, September 2021, Pages 2250-2260.
    J Invest Dermatol. 2025 May 21:S0022-202X(24)03018.
    PubMed    
    
    
    
25. GELFAND JM
    The Visceral Relationship of Psoriasis and Obesity.
    J Invest Dermatol. 2025 May 21:S0022-202X(25)00456.
    PubMed    
    
    
    
26. GEHLHAUSEN JR, Kong Y, Baker E, Ramachandran S, et al
    Cutaneous lupus features specialized stromal niches and altered retroelement expression.
    J Invest Dermatol. 2025 May 21:S0022-202X(25)00488.
    PubMed     Abstract available
    
    
    
27. PARAJULI N, Wang Q, Wang J, Yin C, et al
    MicroRNA-17-92 regulate skin Langerhans cell embryonic development through targeting cell proliferation pathways.
    J Invest Dermatol. 2025 May 21:S0022-202X(25)00493.
    PubMed    
    
    
    
28. BAEZ E, Gyldenlove M, Ben Abdallah H, Emmanuel T, et al
    Oral roflumilast suppresses pro-inflammatory cytokine signaling and reduces CD4+ T cell and neutrophil infiltration in psoriasis.
    J Invest Dermatol. 2025 May 20:S0022-202X(25)00491.
    PubMed     Abstract available
    
    
    
29. ZHANG J, Yu Y, Zhao P, Yuan L, et al
    Clinical characteristics of hand eczema and its association with atopic dermatitis in the Chinese population: A multicenter cross-sectional study.
    J Invest Dermatol. 2025 May 19:S0022-202X(25)00486.
    PubMed     Abstract available
    
    
    
30. POLO-SILVEIRA L, Dusza SW, Kentley J, Marchetti MA, et al
    Cutaneous Melanoma Risk Assessment Among Individuals with a High-Risk Nevus Phenotype.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00478.
    PubMed    
    
    
    
31. FOWLER EA, Sacramento LA, Bowman BA, Lee B, et al
    Hypoxia and IL-15 cooperate to induce perforin expression by CD8 T cells and promote damage to the skin in murine cutaneous leishmaniasis.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00479.
    PubMed     Abstract available
    
    
    
32. RICCI LARA MA, Frutos EL, Rodriguez Kowalczuk MV, Ferraresso MG, et al
    External Validation of an AI Ensemble for Skin Cancer Detection: Enhancing Diagnostic Performance on Dermoscopic Images.
    J Invest Dermatol. 2025 May 9:S0022-202X(25)00469.
    PubMed    
    
    
    
33. KOTKOWSKA ZK, Haunerdinger V, Waeckerle-Men Y, Kolm-Djamei I, et al
    Inflammatory cutaneous reactions with systemic CD8(+) T-cell responses upon photochemical internalization of antigens in mice.
    J Invest Dermatol. 2025 May 8:S0022-202X(25)00467.
    PubMed     Abstract available
    
    
    
34. RECKA N, Simons A, Cornell RA, Van Otterloo E, et al
    Epidermal loss of PRMT5 leads to the emergence of an atypical basal keratinocyte-like cell population and defective skin stratification.
    J Invest Dermatol. 2025 May 6:S0022-202X(25)00449.
    PubMed     Abstract available
    
    
    
35. WANG J, Sun S, Guay H, Chang D, et al
    Classification of skin transcriptome reveals two molecular subtypes in hidradenitis suppurativa.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00463.
    PubMed    
    
    
    
36. LEE M, Mikol V, Truong V, Attieh E, et al
    Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2a Trial.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00462.
    PubMed    
    
    
    
37. FAHMY LM, Adeuyan OO, de Jong A
    CD1a and Lipids as Mediators of T Cell Activation in the Skin.
    J Invest Dermatol. 2025 May 3:S0022-202X(25)00383.
    PubMed     Abstract available
    
    
    
38. MALACTOU C, Hayes M, Zhang T, Ward S, et al
    Eosinophils and bioactive lipid mediators regulate skin inflammation and cancer growth.
    J Invest Dermatol. 2025 May 2:S0022-202X(25)00461.
    PubMed     Abstract available
    
    
    
39. JIA BB, Sun BK, Lee EY, Ren B, et al
    Emerging Techniques in Spatial Multiomics: Fundamental Principles and Applications to Dermatology.
    J Invest Dermatol. 2025;145:1017-1032.
    PubMed     Abstract available
    
    
    
40. KUCERA K, Zenzola N, Hudspeth A, Dubnicka M, et al
    Evaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug Products.
    J Invest Dermatol. 2025;145:1147-1154.
    PubMed     Abstract available
    
    
    
41. YOSHIMOTO N, Muramastsu K, Ito T, Zheng M, et al
    Type XVII Collagen-Specific CD4(+) T Cells Induce Bullous Pemphigoid by Producing IL-5.
    J Invest Dermatol. 2025;145:1092-1104.
    PubMed     Abstract available
    
    
    
42. DOELEMAN T, Brussee S, Hondelink LM, Westerbeek DWF, et al
    Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept Study.
    J Invest Dermatol. 2025;145:1127-1134.
    PubMed     Abstract available
    
    
    
43. SANABRIA-DE LA TORRE R, Montero-Vilchez T, Garcia-Gavin J, Arias-Santiago S, et al
    Current Insights on Lipidomics in Dermatology: A Systematic Review.
    J Invest Dermatol. 2025;145:1105-1116.
    PubMed     Abstract available
    
    
    April 2025
44. ESTRACH S, Vivier CM, Tosello L, Tissot FS, et al
    Epithelial Fibronectin meshwork controls skin regeneration.
    J Invest Dermatol. 2025 Apr 30:S0022-202X(25)00458.
    PubMed     Abstract available
    
    
    
45. VIIKLEPP K, Knuutila JS, Nissinen L, Siljamaki E, et al
    Expression of C1q by macrophages and fibroblasts in tumor microenvironment is associated with progression and metastasis of cutaneous squamous cell carcinoma.
    J Invest Dermatol. 2025 Apr 29:S0022-202X(25)00446.
    PubMed     Abstract available
    
    
    
46. RAMESSUR R, Saklatvala J, Loset M, Thomas LF, et al
    Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population-Based Biobank.
    J Invest Dermatol. 2025 Apr 25:S0022-202X(25)00391.
    PubMed    
    
    
    
47. EYLENBOSCH A, Lambert JLW
    One Step Closer to Personalized Dosing of Biologics in Psoriasis.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00375.
    PubMed    
    
    
    
48. CHEN S, Yarygina O, Gutierrez E, Silvers DN, et al
    Transcriptional signature for dysplastic epidermal development in human pre-malignant skin.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00418.
    PubMed    
    
    
    
49. LECUMBERRI A, Berna-Rico E, Gelfand JM, Svedbom A, et al
    Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00377.
    PubMed     Abstract available
    
    
    
50. RIACHI M, Bryant D, Ellis J, Hughes C, et al
    Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseases.
    J Invest Dermatol. 2025 Apr 22:S0022-202X(25)00414.
    PubMed     Abstract available
    
    
    
51. MERHI R, Boniface K, Seneschal J
    Unveiling the Unseen: Exploring Cellular Dynamics in Nonlesional Vitiligo Skin.
    J Invest Dermatol. 2025 Apr 22:S0022-202X(25)00128.
    PubMed     Abstract available
    
    
    
52. OKUNO R, Hasegawa S, Hasebe Y, Kawagishi-Hotta M, et al
    Site-specific expression of HOXA genes in skin and its effect on skin elasticity.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00417.
    PubMed     Abstract available
    
    
    
53. ZHU Y, Zhang C
    Between Light and Shadow: The Enigma of Nonlesional Skin in Vitiligo.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00127.
    PubMed    
    
    
    
54. PATRA V, Trajanoski S, Joshi A, Lenief V, et al
    Urocanase-positive skin resident bacteria metabolize cis-urocanic acid and in turn reduce the immunosuppressive properties of UV radiation.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00405.
    PubMed     Abstract available
    
    
    
55. MIECZKOWSKI K, Bakiri L, Griss J, Wagner EF, et al
    A sex-specific anti-inflammatory role for p62 in psoriasis-like disease.
    J Invest Dermatol. 2025 Apr 19:S0022-202X(25)00413.
    PubMed     Abstract available
    
    
    
56. WANG J, Zhang Y, Xie F, Liu J, et al
    Enhancing Diagnosis of Psoriasis and Inflammatory Skin Diseases: A Spatially Aligned Multimodal Model Integrating Clinical and Dermoscopic Images.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00402.
    PubMed     Abstract available
    
    
    
57. DEBERG HA, Fahning ML, Varkhande SR, Schlenker JD, et al
    T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00401.
    PubMed     Abstract available
    
    
    
58. DONG L, Wu N, Cai Z, Yan S, et al
    Tolerogenic monocyte-derived langerhans cells promote melanoma progression and immunotherapy resistance through AhR-COX2 activation.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00404.
    PubMed     Abstract available
    
    
    
59. YAMAMURA S, Horiguchi H, Kadomatsu T, Miyata K, et al
    Aging-associated mitochondrial decline accelerates skin aging and obesity.
    J Invest Dermatol. 2025 Apr 8:S0022-202X(25)00395.
    PubMed     Abstract available
    
    
    
60. WARREN WG, Osborn M, Yates A, O'Sullivan SE, et al
    ART26.12, A FATTY ACID-BINDING PROTEIN 5 INHIBITOR, SHOWS EFFICACY IN PRECLINICAL PSORIASIS MODELS.
    J Invest Dermatol. 2025 Apr 8:S0022-202X(25)00393.
    PubMed     Abstract available
    
    
    
61. DOLIVO DM, Rodrigues AE, Mustoe TA, Galiano RD, et al
    Ethacrynic acid mitigates skin fibrosis through downregulation of S100 family damage-associated molecular pattern expression in the epidermis.
    J Invest Dermatol. 2025 Apr 8:S0022-202X(25)00396.
    PubMed    
    
    
    
62. SU L, Wang D, Purwin TJ, Ran S, et al
    Selective USP7 inhibition synergizes with MEK1/2 inhibitor to enhance immune responses and potentiate anti-PD-1 therapy in NRAS mutant melanoma.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00384.
    PubMed     Abstract available
    
    
    
63. STAMATAS GN, Insel R, Sorensen N, Palleja A, et al
    Shifts in Infant Skin Microbiome at 2 Months following Short-term Emollient Use from Birth are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00380.
    PubMed    
    
    
    
64. FREEMAN E, Anwar S, Ahmad N, Fuller LC, et al
    Skin Health at Risk? Examining the Implications of a United States Exit from the World Health Organization.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00308.
    PubMed    
    
    
    
65. CHEN M, Chen M, Liu L, Yan P, et al
    Transcriptome and chromatin landscape changes associated with pathogenesis of psoriasis in memory Th and memory Treg cells.
    J Invest Dermatol. 2025 Apr 3:S0022-202X(25)00382.
    PubMed    
    
    
    
66. XIE J, Ma C, Zhao S, Wu D, et al
    Deubiquitination by USP7 Stabilizes JunD and Activates AIFM2 (FSP1) to Inhibit Ferroptosis in Melanoma.
    J Invest Dermatol. 2025 Apr 3:S0022-202X(25)00381.
    PubMed     Abstract available
    
    
    
67. PIGORS M, Goletz S, Wang Y, Emtenani S, et al
    Anti-Laminin beta4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin alpha3 and gamma1/2 Chains.
    J Invest Dermatol. 2025;145:821-830.
    PubMed     Abstract available
    
    
    
68. MAMMANO F, Paller AS, White TW
    Connexin Hemichannel Inhibition and Human Genodermatoses.
    J Invest Dermatol. 2025;145:790-799.
    PubMed     Abstract available
    
    
    
69. ZHENG Y, Gong W, Wu Z, Zhang S, et al
    FGF21 Ameliorates Fibroblasts Activation and Systemic Sclerosis by Inhibiting CK2alpha/GLI2 Signaling Axis.
    J Invest Dermatol. 2025;145:842-853.
    PubMed     Abstract available
    
    
    
70. KANG TJ, Lee SY, Yoon S, Kim EG, et al
    PCSK9 Inhibitors and the Risk of Vitiligo: A Mendelian Randomization Study.
    J Invest Dermatol. 2025;145:812-820.
    PubMed     Abstract available
    
    
    
71. VASUDEVAN SS, Patel T, DiGiovanni J, Nathan CO, et al
    Current Efficacy, Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    J Invest Dermatol. 2025 Apr 1:S0022-202X(25)00379.
    PubMed    
    
    
    March 2025
72. LWIN SM, Griffiths CEM
    The Burma Skincare Initiative Spirit of Partnership Garden: Storytelling through Horticulture.
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00291.
    PubMed    
    
    
    
73. HUI-BECKMAN JW, Kim BE, Lyubchenko T, Hall CF, et al
    Repeated Temperature Fluctuation Exposure Causes Prolonged Skin Barrier Dysfunction.
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00373.
    PubMed    
    
    
    
74. YANG VB, Sams CM, Francis SN, Daneshjou R, et al
    Uncovering Disparities in Skin Tone Representation Among AI Vision-Language Models (VLMs).
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00374.
    PubMed    
    
    
    
75. WANG Y, Wang X, Ming X, Gu Y, et al
    Development of an Artificial Intelligence-Based Model to Precisely Measure Body Surface Area in Psoriasis.
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00376.
    PubMed    
    
    
    
76. HAUGH AM, Fisher DE, Lawrence DP
    Tumor-Infiltrating Lymphocyte Therapy for Melanoma Has Arrived (at Last).
    J Invest Dermatol. 2025 Mar 27:S0022-202X(24)03033.
    PubMed    
    
    
    
77. GU J, Weller R
    Suberythemal Sun and the Skin.
    J Invest Dermatol. 2025 Mar 27:S0022-202X(25)00307.
    PubMed    
    
    
    
78. AL-JANABI A, Martin P, Simpson C, Rhys H, et al
    Blood single cell transcriptomic and proteomic signatures of paradoxical eczema in psoriasis patients treated with biologics.
    J Invest Dermatol. 2025 Mar 27:S0022-202X(25)00370.
    PubMed     Abstract available
    
    
    
79. ZHENG L, Soyer HP, Janda M, Jayasinghe D, et al
    An overview of data analysis approaches and biases in unveiling the impact of COVID 19 on melanoma diagnosis.
    J Invest Dermatol. 2025 Mar 25:S0022-202X(25)00371.
    PubMed    
    
    
    
80. QUAN T, Qin Z, He T, Fisher GJ, et al
    Integrin alpha11beta1 as a Key Collagen Receptor in Human Skin Dermis: Insight into Fibroblast Function and Skin Dermal Aging.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00364.
    PubMed     Abstract available
    
    
    
81. ZHANG H, Tang S, Chen X, Wang M, et al
    Association Between Emotional Distress and Atopic Dermatitis: A Cross-Sectional Study.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00365.
    PubMed    
    
    
    
82. MARGUIER A, Mathiot J, NDao B, Wespiser M, et al
    TIE-2 expressing monocytic myeloid-derived suppressor cells are involved in resistance to anti-PD-1 therapy mediated by angiopoietin 2 in melanoma patients.
    J Invest Dermatol. 2025 Mar 18:S0022-202X(25)00327.
    PubMed    
    
    
    
83. KIDACKI M, Cho C, Lopez-Giraldez F, Breidbart R, et al
    Spatial transcriptomics reveals differential inflammatory pathways in discoid lupus erythematosus and lichen planus.
    J Invest Dermatol. 2025 Mar 18:S0022-202X(25)00324.
    PubMed    
    
    
    
84. MOCHIZUKI H, Brooks SG, Mahmoud R, Andrade LF, et al
    The effect of IL17 antibody in psoriasis on brain structural morphology reveals significant changes in the precuneus.
    J Invest Dermatol. 2025 Mar 13:S0022-202X(25)00322.
    PubMed    
    
    
    
85. MA K, Shafique N, Tortorello G, Dheer A, et al
    Significance of Prognostic Factors Across Tumor Thicknesses in Melanoma: A National Cohort Study.
    J Invest Dermatol. 2025 Mar 12:S0022-202X(25)00321.
    PubMed    
    
    
    
86. SCOTT RW
    The Beauty of Fibroblasts Is Several Skin Layers Deep and Much Deeper.
    J Invest Dermatol. 2025 Mar 10:S0022-202X(25)00126.
    PubMed    
    
    
    
87. LEBTIG M, Peschel A, Kretschmer D
    Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis.
    J Invest Dermatol. 2025 Mar 9:S0022-202X(25)00100.
    PubMed     Abstract available
    
    
    
88. WANG Y, Yin H, Li Z, Wu H, et al
    Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis.
    J Invest Dermatol. 2025 Mar 7:S0022-202X(25)00311.
    PubMed     Abstract available
    
    
    
89. LANE M, Aubert A, Prudova A, Liu F, et al
    Extracellular Granzyme B mediates degradation of Collagen XVII in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2025 Mar 6:S0022-202X(25)00306.
    PubMed    
    
    
    
90. YUE L, Pang B, Li G, Zhang C, et al
    Endothelial Piezo1 mediates barrier dysfunction and NLRP3 inflammasomes activation in psoriasis.
    J Invest Dermatol. 2025 Mar 5:S0022-202X(25)00303.
    PubMed     Abstract available
    
    
    
91. LEE JY, Kim HE, Lee ST, Park J, et al
    The repurposing of Nitazoxanide for psoriasis treatment exerts therapeutic effects through skin metabolic reprogramming.
    J Invest Dermatol. 2025 Mar 3:S0022-202X(25)00298.
    PubMed     Abstract available
    
    
    
92. CHANG J, Shin K, Lewis JM, Suh HW, et al
    Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol-Coated Biodegradable Nanoparticles.
    J Invest Dermatol. 2025;145:593-604.
    PubMed     Abstract available
    
    
    
93. SHISHIDO-TAKAHASHI N, Garcet S, Cueto I, Miura S, et al
    Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa.
    J Invest Dermatol. 2025;145:536-547.
    PubMed     Abstract available
    
    
    
94. YANG H, Chen Y, Wang L, Gan B, et al
    The Fungal Secretory Peptide Micasin Induces Itch by Activating MRGPRX1/C11/A1 on Peripheral Neurons.
    J Invest Dermatol. 2025;145:618-630.
    PubMed     Abstract available
    
    
    February 2025
95. RAMOS R, Plikus MV
    Skin-Associated Cartilage Is a Distinct Type of Lipid-Filled Tissue.
    J Invest Dermatol. 2025 Feb 28:S0022-202X(25)00092.
    PubMed    
    
    
    
96. KUPPANDA PM, Janda M, Soyer HP, Caffery LJ, et al
    What Are Patients' Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00080.
    PubMed     Abstract available
    
    
    
97. INGEN-HOUSZ-ORO S, Matei I, Gaillet A, Gueudry J, et al
    Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00078.
    PubMed     Abstract available
    
    
    
98. INGEN-HOUSZ-ORO S, French LE, Wolkenstein P
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic Strategies.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00079.
    PubMed    
    
    
    
99. DEL VECCHIO G, Nguyen NPN, Ouyang K, Odhiambo CO, et al
    Functional Dynamics of Dendritic Cells in Response to Cutibacterium acnes Strains Associated with Healthy and Acne-prone Skin.
    J Invest Dermatol. 2025 Feb 26:S0022-202X(25)00292.
    PubMed    
    
    
    
100. MOON H, Kim M, Sim H, Hong S, et al
     Comprehensive profiling of genetic and non-genetic factors that influence skin traits in Asian women from four countries.
     J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00290.
     PubMed     Abstract available
     
     
     
101. KAMP E, Ascott A, George SMC
     Eczema Severity Scoring in Skin of Color: A Review of Current Best Practice and Need for Future Improvement.
     J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00099.
     PubMed     Abstract available
     
     
     
102. ZHOU X, Jin Y, Zhu Y, Luo X, et al
     The Role of Crosstalk between Nets and Keratinocytes in Skin Immunity.
     J Invest Dermatol. 2025 Feb 21:S0022-202X(25)00012.
     PubMed     Abstract available
     
     
     
103. SCHWARZ CW, Blegvad C, Baudry D, Tosi I, et al
     Genetic Risk Factors in Childhood Psoriasis.
     J Invest Dermatol. 2025 Feb 19:S0022-202X(25)00117.
     PubMed    
     
     
     
104. KIDACKI M, Cho C, Lopez-Giraldez F, Huang B, et al
     PD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation.
     J Invest Dermatol. 2025 Feb 19:S0022-202X(25)00116.
     PubMed     Abstract available
     
     
     
105. THOMAS CM, Baudry D, Arkir Z, Coker B, et al
     Personalising biologic therapy in psoriasis: Development, validation and user-testing of a precision dosing dashboard.
     J Invest Dermatol. 2025 Feb 19:S0022-202X(25)00118.
     PubMed     Abstract available
     
     
     
106. TAKAISHI M, Ishimoto T, Kataoka S, Yagyu KI, et al
     A Newly Identified Spliceosomal Protein AHED is Essential for Homeostasis of the Epidermis.
     J Invest Dermatol. 2025 Feb 18:S0022-202X(25)00111.
     PubMed     Abstract available
     
     
     
107. BEN ABDALLAH H, Iversen L, Johansen C
     The differential roles of heat shock protein 90 isoforms in skin inflammation: Anti-inflammatory potential of TRAP1 inhibition.
     J Invest Dermatol. 2025 Feb 18:S0022-202X(25)00110.
     PubMed     Abstract available
     
     
     
108. DE BOER F, Kezic S, van der Lelie G, Motazedi E, et al
     Effect of Repeated Low Dose UVR Exposure on Skin Inflammation Threshold, Skin Biomarkers and Vitamin D in Healthy Adults.
     J Invest Dermatol. 2025 Feb 14:S0022-202X(25)00106.
     PubMed     Abstract available
     
     
     
109. AZIMI A, Bi L, Bonfil A, Teh R, et al
     Integrated analysis of proteomic and dermoscopy imaging data improves non-invasive classification of benign nevi and melanoma.
     J Invest Dermatol. 2025 Feb 13:S0022-202X(25)00102.
     PubMed    
     
     
     
110. MATSUMURA Y, Kume M, Furuta J, Koguchi-Yoshioka H, et al
     Possible role of IL-23 inhibition in reduction of circulating IL-17A(+) CD103(+) memory CD8 T cells in psoriasis.
     J Invest Dermatol. 2025 Feb 11:S0022-202X(25)00101.
     PubMed    
     
     
     
111. VESELY MD, Lizzul PF, Klekotka P, Joller N, et al
     Immune Checkpoint Agonists for Inflammatory Skin Diseases.
     J Invest Dermatol. 2025 Feb 8:S0022-202X(25)00031.
     PubMed    
     
     
     
112. WHITESIDE TL
     Transfer of Oncologic Signals from Melanoma Cells to Benign Melanocytes by Circulating Tumor-Derived Extracellular Vesicles.
     J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00025.
     PubMed    
     
     
     
113. ADAM E, Leitgeb B, Danis J, Hajdu A, et al
     Truncating CYLD pathogenic variants in CYLD cutaneous syndrome distinctly influence CYLD proteostasis and NF-kappaB signaling.
     J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00089.
     PubMed    
     
     
     
114. KIM YH, Myeong SY, Kim Y, Maeng J, et al
     Secreted Phosphoprotein 1-CD44s Axis Downregulation Promotes Melanocyte Senescence through ROS Generation.
     J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00088.
     PubMed    
     
     
     
115. MEROLA JF, Zhang AJ, Childs BA, Li M, et al
     INTER-RATER AND INTRA-RATER RELIABILITY OF THE CUTANEOUS LUPUS ACTIVITY-INVESTIGATOR GLOBAL ASSESSMENT-REVISED (CLA-IGA-R) INSTRUMENT.
     J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00093.
     PubMed    
     
     
     
116. SLOMINSKI AT, Kim TK, Janjetovic Z, Slominski RM, et al
     Melatonin and the Skin: Current Progress and Perspectives for Human Health.
     J Invest Dermatol. 2025 Feb 6:S0022-202X(24)03030.
     PubMed     Abstract available
     
     
     
117. RICHARD W, Moga A, Genain G, Amalric N, et al
     Electrochemistry to monitor skin barrier: a proof-of-concept study on skin differentiation compared to corneometry, TEWL measurement, and High-Performance Liquid Chromatography.
     J Invest Dermatol. 2025 Feb 6:S0022-202X(25)00091.
     PubMed    
     
     
     
118. HINZ B
     HIF-1 Un-LOX Mechanical Mechanisms in Psoriasis.
     J Invest Dermatol. 2025 Feb 5:S0022-202X(25)00026.
     PubMed    
     
     
     
119. GRADA A, Issa N
     Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work?
     J Invest Dermatol. 2025 Feb 4:S0022-202X(25)00011.
     PubMed    
     
     
     
120. WONG ZY, Ou KQ, Wong ZN, Faderani R, et al
     Comment on "Does Sex Matter? Temporal Analyses of Melanoma Trends among Men and Women Suggest Etiologic Heterogeneity.".
     J Invest Dermatol. 2025 Feb 4:S0022-202X(25)00005.
     PubMed    
     
     
     
121. KWATRA SG, Stander S, Yosipovitch G, Kim BS, et al
     Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation.
     J Invest Dermatol. 2025;145:249-256.
     PubMed     Abstract available
     
     
     
122. CHEN Q, Zheng J, Bian Q
     Cell Fate Regulation During the Development of Infantile Hemangioma.
     J Invest Dermatol. 2025;145:266-279.
     PubMed     Abstract available
     
     
     
123. ERTEL A, Anderegg U, Franz S, Saalbach A, et al
     Dermal White Adipose Tissue-Derived Il-33 Regulates Il-4/13 Expression in Myeloid Cells during Inflammation.
     J Invest Dermatol. 2025;145:370-382.
     PubMed     Abstract available
     
     
     
124. LI S, Wu Y, Bu D, Hu L, et al
     SERPINB7 Deficiency Increases Legumain Activity and Impairs the Epidermal Barrier in Nagashima-Type Palmoplantar Keratoderma.
     J Invest Dermatol. 2025;145:359-369.
     PubMed     Abstract available
     
     
     
125. BACHIRI K, Kantar D, Laurent EMN, Gaboriaud P, et al
     DNA Damage Stress Control Is a Truncated Large T Antigen and Euchromatic Histone Lysine Methyltransferase 2-Dependent Central Feature of Merkel Cell Carcinoma.
     J Invest Dermatol. 2025;145:400-410.
     PubMed     Abstract available
     
     
     
126. NATSUGA K, Cipolat S, Watt FM
     Corrigendum to 'Increased Bacterial Load and Expression of Antimicrobial Peptides in Skin of Barrier-Deficient Mice with Reduced Cancer Susceptibility' Journal of Investigative Dermatology, Volume 136, Issue 1, January 2016, Pages 99-106.
     J Invest Dermatol. 2025;145:459.
     PubMed    
     
     
     January 2025
127. WU S, Wang D, Gu X, Xiao R, et al
     Identifying Research Hotspots and Trends in Psoriasis Literature: Autotuned Topic Modeling with Agent.
     J Invest Dermatol. 2025 Jan 31:S0022-202X(25)00086.
     PubMed     Abstract available
     
     
     
128. HU J, Zhao Q, Che D, Peng B, et al
     Epidermal Mechanical Scratching-Induced ROS Exacerbates the Itch-Scratch Cycle via TRPA1 Activation on Mast Cells in Atopic Dermatitis.
     J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00076.
     PubMed     Abstract available
     
     
     
129. KHOSRAVI-HAFSHEJANI T, Werth VP
     Serum IFNalpha as a Biomarker for Cutaneous Lupus: Insights into Disease Activity, Severity, Therapeutic Monitoring and Clinical Trial Application.
     J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00020.
     PubMed    
     
     
     
130. DUAN J, Karri SS, Forouzesh K, Mortimer T, et al
     Designing and Evaluating Circadian Experiments on Mouse Skin.
     J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00018.
     PubMed     Abstract available
     
     
     
131. GU J, Wei B, Duan R, Jin J, et al
     Insight into the Relationship between Congenital Large/Giant Melanocytic Nevi and Satellite Nevi.
     J Invest Dermatol. 2025 Jan 29:S0022-202X(25)00084.
     PubMed    
     
     
     
132. NASSIR S, Yousif M, Li X, Severson KJ, et al
     Multi-omic Sequencing of Intermediate to High-Risk Cutaneous Squamous Cell Carcinoma Identifies Critical Genes and Expression Patterns Associated with Disease and Poor Outcomes.
     J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00082.
     PubMed     Abstract available
     
     
     
133. ABUABARA K, Kidd SA, Ye M, Tully J, et al
     The impact of childhood stressful life events on atopic dermatitis disease activity and severity.
     J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00081.
     PubMed     Abstract available
     
     
     
134. MORIOKA N, Ganier C, Watt FM
     Fetal fibroblast heterogeneity defines dermal architecture during human embryonic skin development.
     J Invest Dermatol. 2025 Jan 27:S0022-202X(25)00077.
     PubMed     Abstract available
     
     
     
135. NAVSARIA LJ, Li Y, Jambusaria A, Wheless LE, et al
     Internal cancers in solid organ transplant recipients with a post-transplant skin cancer: a cohort study.
     J Invest Dermatol. 2025 Jan 24:S0022-202X(25)00030.
     PubMed    
     
     
     
136. INGEN-HOUSZ-ORO S, de Prost N, Wolkenstein P
     Need for Trial Design Change in Epidermal Necrolysis (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis): Example of Cyclosporine.
     J Invest Dermatol. 2025 Jan 22:S0022-202X(24)03047.
     PubMed    
     
     
     
137. GOODERHAM MJ, Mrowietz U, Kadus W, Drda K, et al
     Phase II Randomized Trial of BI 730357, a Novel Oral RORgammat Inhibitor, for Moderate-to-Severe Plaque Psoriasis.
     J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00034.
     PubMed     Abstract available
     
     
     
138. GOHARA Y, Kinoshita R, Tomonobu N, Jiang F, et al
     An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms.
     J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00029.
     PubMed     Abstract available
     
     
     
139. OLESEN CM, Edslev SM, Aasbjerg GN, Yuksel YT, et al
     Subtype specific alterations in the skin microbiome of patients with cutaneous T-cell lymphoma.
     J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00032.
     PubMed    
     
     
     
140. WANG F, Yi C, Zhong Y, Zhou L, et al
     Downregulated TFPI2 accelerates skin aging by repressing cell cycle via PI3K/Akt/CDC6 pathway.
     J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00033.
     PubMed     Abstract available
     
     
     
141. CAVES E, Jussila A, Forni MF, Benvie A, et al
     Atgl-dependent adipocyte lipolysis promotes lipodystrophy and restrains fibrogenic responses during skin fibrosis.
     J Invest Dermatol. 2025 Jan 20:S0022-202X(25)00022.
     PubMed     Abstract available
     
     
     
142. MULLER C, Tschandl P, Rinner C, Kyrgidis A, et al
     The BRAAFF-Annotated Acral Lesions Dataset (BALD): A curated set of dermatoscopic images of acral melanoma and nevi from various sources.
     J Invest Dermatol. 2025 Jan 17:S0022-202X(25)00021.
     PubMed    
     
     
     
143. SHEN A, Arbesman M, Lodha R, Rayman P, et al
     Germline Pathogenic Variant (gPV) Positive Patients with Melanoma Exhibit Improved Response to Checkpoint Inhibitor Immunotherapy.
     J Invest Dermatol. 2025 Jan 13:S0022-202X(25)00004.
     PubMed    
     
     
     
144. WEI Y, Wan Z, Jiang Y, Liu Z, et al
     No Causal Association between ACE Inhibitors and Skin Fibrosis Risk: Evidence from Mendelian Randomization.
     J Invest Dermatol. 2025 Jan 13:S0022-202X(25)00013.
     PubMed    
     
     
     
145. ZHANG M, Li Z, Yang R, Liang L, et al
     Revolutionizing Chronic Wound Treatment: Treating Bleomycin Intralesional Injection-Related Chronic Wounds with 3D Bioprinted Skin Substitutes.
     J Invest Dermatol. 2025 Jan 10:S0022-202X(25)00009.
     PubMed    
     
     
     
146. MOHR C, Li Y, Navsaria LJ, Hinkston CL, et al
     Allogeneic Hematopoietic Stem-Cell Transplant Recipients and Skin Cancer Risk: A Commercial Claims Cohort Study.
     J Invest Dermatol. 2025 Jan 9:S0022-202X(25)00002.
     PubMed    
     
     
     
147. MENG Y, Zhou Q, Dian Y, Zeng F, et al
     Ferroptosis: A Targetable Vulnerability for Melanoma Treatment.
     J Invest Dermatol. 2025 Jan 8:S0022-202X(24)03024.
     PubMed     Abstract available
     
     
     
148. TRIBBLE JT, Brownell I, Cahoon EK, Sargen MR, et al
     A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021.
     J Invest Dermatol. 2025 Jan 6:S0022-202X(25)00001.
     PubMed     Abstract available
     
     
     
149. PERRAY L, Dorgham K, Mathian A, Grolleau C, et al
     Identification of serum IFN-alpha and BAFF levels as potential biomarkers of activity and severity in cutaneous lupus erythematosus.
     J Invest Dermatol. 2025 Jan 6:S0022-202X(24)03053.
     PubMed    
     
     
     
150. MEI H, Dai X, Chen W, Luo R, et al
     Intervening CCL8-CCR8 Signaling Reduces Cutaneous Inflammation and Itch in Mice.
     J Invest Dermatol. 2025 Jan 4:S0022-202X(24)03051.
     PubMed    
     
     
     
151. WANG Z, Hu H, Ou Y, Wang C, et al
     Computer-Aided Assessment of Repigmentation Rates in Vitiligo Patients: Implications for Treatment Efficacy - A Retrospective Study.
     J Invest Dermatol. 2025;145:56-64.
     PubMed     Abstract available
     
     
     
152. SAMPATH AJ, Westerkam LL, Blum FR, Alhusayen R, et al
     Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens.
     J Invest Dermatol. 2025;145:50-55.
     PubMed     Abstract available
     
     
     
153. BRYANT D, Barberan-Martin S, Maeshima R, Del Valle Torres I, et al
     RNA Therapy for Oncogenic NRAS-Driven Nevi Induces Apoptosis.
     J Invest Dermatol. 2025;145:122-134.
     PubMed     Abstract available
     
     
     
154. CAMPBELL AC, Baik JE, Sarker A, Brown S, et al
     Breast Cancer-Related Lymphedema Results in Impaired Epidermal Differentiation and Tight Junction Dysfunction.
     J Invest Dermatol. 2025;145:85-97.
     PubMed     Abstract available
     
     
     
155. BRIOT J, Pons C, Foucher A, Goudouneche D, et al
     Prolyl Endopeptidase Is Involved in Filaggrinolysis and Cornification.
     J Invest Dermatol. 2025;145:98-108.
     PubMed     Abstract available
     
     
     
156. WU S, Fang R, Rietveld MH, Torremans JRG, et al
     Identification of Small-Molecule Inhibitors Targeting Different Signaling Pathways in Cancer-Associated Fibroblast Reprogramming under Tumor-Stroma Interaction.
     J Invest Dermatol. 2025;145:65-76.
     PubMed     Abstract available
     
     
     
157. MOHANTY C, Singh CK, Daccache JA, Damsky W, et al
     Granuloma Annulare Exhibits Mixed Immune and Macrophage Polarization Profiles with Spatial Transcriptomics.
     J Invest Dermatol. 2025;145:109-121.
     PubMed     Abstract available
     
     
     December 2024
158. LEE S, Jung DM, Kang BM, Yoo JG, et al
     Expression of FABP4 in Human Sebaceous Glands and Its Role in Sebum Production: A New Regulator of Sebum Production.
     J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03050.
     PubMed    
     
     
     
159. DUONG T, Hafer R, Yang HY, Tolotta J, et al
     The Risk of Developing Keratinocyte Malignancies in Patients with Cutaneous T-cell Lymphoma.
     J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03046.
     PubMed    
     
     
     
160. KURZEN N, Mubarak M, Eigemann J, Seiringer P, et al
     Death associated protein kinase 1 dampens keratinocyte necroptosis and expression of inflammatory genes in lichen planus.
     J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03039.
     PubMed     Abstract available
     
     
     
161. BLOT L, Bzioueche H, Heim M, Cheli Y, et al
     CLEC12B regulates melanocyte immunity and homeostasis in the skin through the STAT1/IRF1 axis.
     J Invest Dermatol. 2024 Dec 28:S0022-202X(24)03038.
     PubMed     Abstract available
     
     
     
162. AZEEM M, Helal M, Klein-Hessling S, Serfling E, et al
     NFATc1 fosters allergic contact dermatitis responses by enhancing the induction of IL-17-producing CD8 cells.
     J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03036.
     PubMed     Abstract available
     
     
     
163. STROTHER C, Bouffard N, Smolynets O, Graham NR, et al
     Localized inflammation in dengue vaccine-induced skin rash is not associated with continuous presence of dengue virus genome.
     J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03037.
     PubMed     Abstract available
     
     
     
164. LEE KJ, Kao YC, Smit DJ, Betz-Stablein B, et al
     Mitochondrial deletion(4977) abundance in melanoma-adjacent skin.
     J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03026.
     PubMed    
     
     
     
165. SHIME H, Odanaka M, Imai M, Sugiyama D, et al
     Ultraviolet-B irradiation expands skin-resident CD81(+)Foxp3(+) regulatory T cells with a highly activated phenotype.
     J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03025.
     PubMed     Abstract available
     
     
     
166. THAKKER S, Arbesman J, Klein JC, Sunshine JC, et al
     Three-Dimensional Nuclear Architecture and Genomic Structural Variations in Melanoma.
     J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03032.
     PubMed    
     
     
     
167. BECCACECE I, Burstein VL, Almeida MA, Gareca JC, et al
     Cutaneous innate lymphoid populations drive IL-17A-mediated immunity in Nannizzia gypsea dermatophytosis.
     J Invest Dermatol. 2024 Dec 23:S0022-202X(24)03029.
     PubMed     Abstract available
     
     
     
168. TULIC MK, Kovacs D, Bastonini E, Briganti S, et al
     Focusing on the Dark Side of the Moon: Involvement of the Nonlesional Skin in Vitiligo.
     J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02886.
     PubMed     Abstract available
     
     
     
169. ISKANDAR RJ, Drucker AM
     A Framework to Efficiently Monitor the Comparative Safety of Systemic Immunomodulatory Medications for Atopic Dermatitis.
     J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02961.
     PubMed    
     
     
     
170. USOLTSEV D, Njauw CN, Ji Z, Kumar R, et al
     Analysis of variants induced by combined ex vivo irradiation and in vivo tumorigenesis suggests a role for the ZNF831 p.R1393Q mutation in cutaneous melanoma development.
     J Invest Dermatol. 2024 Dec 13:S0022-202X(24)03015.
     PubMed     Abstract available
     
     
     
171. TORRES M, Silberberg G, Vegvari A, Zubarev RA, et al
     The temporal dynamics of proteins in aged skin wound healing and comparison to gene expression.
     J Invest Dermatol. 2024 Dec 13:S0022-202X(24)03014.
     PubMed    
     
     
     
172. BRAHIMI N, Croitoru D, Saidoune F, Zabihi H, et al
     From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.
     J Invest Dermatol. 2024 Dec 10:S0022-202X(24)01883.
     PubMed     Abstract available
     
     
     
173. SALAVESSA L, Delevoye C
     Trash to Treasure: The (Trans)formation of Pigment Organelles in Skin Keratinocytes.
     J Invest Dermatol. 2024 Dec 8:S0022-202X(24)02901.
     PubMed    
     
     
     
174. HAO J, Xu H, Luo M, Yu W, et al
     Corrigendum to The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy [Journal of Investigative Dermatology, Volume 138, Issue 1, January 2018, Pages 159-170].
     J Invest Dermatol. 2024 Dec 6:S0022-202X(24)02184.
     PubMed    
     
     
     
175. YASSKY D, Kim BS
     Mouse Models of Itch.
     J Invest Dermatol. 2024;144:2634-2644.
     PubMed     Abstract available
     
     
     
176. STEINBECK BJ, Gao XD, McElroy AN, Pandey S, et al
     Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa.
     J Invest Dermatol. 2024;144:2764-2777.
     PubMed     Abstract available
     
     
     
177. MURTHY S, Patzelt S, Kunstner A, Busch H, et al
     Intravenous Ig Ameliorates Disease in a Murine Model of Anti-Laminin 332 Mucous Membrane Pemphigoid.
     J Invest Dermatol. 2024;144:2671-2681.
     PubMed     Abstract available
     
     
     
178. STEINERT L, Fuchs M, Sigmund AM, Didona D, et al
     Desmosomal Hyper-Adhesion Affects Direct Inhibition of Desmoglein Interactions in Pemphigus.
     J Invest Dermatol. 2024;144:2682-2694.
     PubMed     Abstract available
     
     
     November 2024
179. LIU X, Janknecht R, Asadbeigi SN, Perry L, et al
     The influence of melanoma extracellular vesicles on benign melanocytes: a role for PRAME in modulation of the tumor microenvironment.
     J Invest Dermatol. 2024 Nov 26:S0022-202X(24)02959.
     PubMed     Abstract available
     
     
     
180. BALSINI P, Weinzettl P, Samardzic D, Zila N, et al
     Stiffness-dependent LOX regulation via HIF-1 drives extracellular matrix modifications in psoriasis.
     J Invest Dermatol. 2024 Nov 25:S0022-202X(24)02958.
     PubMed     Abstract available
     
     
     
181. TONG X, Burks HE, Ren Z, Koetsier JL, et al
     Crosstalk in Skin: Loss of Desmoglein 1 in Keratinocytes Inhibits BRAF(V600E)-induced Cellular Senescence in Human Melanocytes.
     J Invest Dermatol. 2024 Nov 22:S0022-202X(24)02955.
     PubMed     Abstract available
     
     
     
182. BOIX J, Knuever J, Niehoff N, Sen A, et al
     Constitutive HIF-1alpha expression in the epidermis fuels proliferation and is essential for effective barrier formation.
     J Invest Dermatol. 2024 Nov 21:S0022-202X(24)02951.
     PubMed     Abstract available
     
     
     
183. YU Z, Tang X, Chen Z, Hu Y, et al
     Role of ADAM10/17-mediated Cleavage of LAG3 in the Impairment of Immunosuppression in Psoriasis.
     J Invest Dermatol. 2024 Nov 19:S0022-202X(24)02948.
     PubMed     Abstract available
     
     
     
184. YANG J, Liu Z, Hu X, Zhang X, et al
     Skin-resident gammadelta T cells mediate potent and selective antitumor cytotoxicity through directed chemotactic migration and mobilization of cytotoxic granules.
     J Invest Dermatol. 2024 Nov 19:S0022-202X(24)02949.
     PubMed     Abstract available
     
     
     
185. SEYRAN B, Avila I, Galvan C, Robles G, et al
     Inhibition of pyruvate oxidation diminishes melanoma progression.
     J Invest Dermatol. 2024 Nov 18:S0022-202X(24)02902.
     PubMed    
     
     
     
186. LEE SS, Martinez Pena EG, Willis AA, Wang CC, et al
     Cell Therapy and the Skin: Great Potential but in Need of Optimization.
     J Invest Dermatol. 2024 Nov 12:S0022-202X(24)02159.
     PubMed     Abstract available
     
     
     
187. PARK HJ, Lee SW, Kim TC, Park YH, et al
     Topical Application of Nano-sized Graphene Oxide Cream Ameliorates Acute Skin Inflammation in Mice.
     J Invest Dermatol. 2024 Nov 8:S0022-202X(24)02877.
     PubMed     Abstract available
     
     
     
188. ALDEA D, Macagno N, Marechal E, Moreno M, et al
     Deconvoluted methylation profiles discriminate between closely related melanocytic nevi.
     J Invest Dermatol. 2024 Nov 8:S0022-202X(24)02878.
     PubMed    
     
     
     
189. GUO L, Bilimoria SN, Kikuchi R, Hao A, et al
     Chronic Obstructive Pulmonary Disease Outcomes in Psoriasis Patients.
     J Invest Dermatol. 2024 Nov 8:S0022-202X(24)02879.
     PubMed    
     
     
     
190. HORSLEY V, Dadzie OE, Hall R, Jablonski NG, et al
     Disentangling Race from Skin Color in Modern Biology and Medicine.
     J Invest Dermatol. 2024 Nov 6:S0022-202X(24)02108.
     PubMed     Abstract available
     
     
     
191. YEW YW, Loh M, Brown SJ
     Understanding Atopic Dermatitis in Asian and European Population Cohorts Using Complementary Omics Techniques.
     J Invest Dermatol. 2024 Nov 5:S0022-202X(24)02171.
     PubMed     Abstract available
     
     
     
192. LOMAKIN IB, Devarkar SC, Grada A, Bunick CG, et al
     Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin.
     J Invest Dermatol. 2024;144:2553-2561.
     PubMed     Abstract available
     
     
     
193. ZEYER KA, Bornert O, Nelea V, Bao X, et al
     Dipeptidyl Peptidase-4-Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix.
     J Invest Dermatol. 2024;144:2477-2487.
     PubMed     Abstract available
     
     
     
194. PATEL J, Deng J, Kambala A, Lee KK, et al
     Spatial Mass Cytometry-Based Single-Cell Imaging Reveals a Disrupted Epithelial-Immune Axis in Prurigo Nodularis.
     J Invest Dermatol. 2024;144:2501-2512.
     PubMed     Abstract available
     
     
     
195. GUTIERREZ-GARCIA C, Robles-Espinoza CD
     MicroRNA Quantification as an Accurate and Cost-Effective Method to Diagnose Acral Melanoma.
     J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02098.
     PubMed    
     
     
     
196. MASISON J, Lehmann HP, Wan J
     Utilization of Computable Phenotypes in Electronic Health Record Research: A Review and Case Study in Atopic Dermatitis.
     J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02103.
     PubMed     Abstract available
     
     
     
197. WEI G, Tran MM, Orsillo L, Mirza FN, et al
     A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region.
     J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02172.
     PubMed     Abstract available
     
     
     October 2024
198. NAKATSUJI T, Cheng JY, Butcher A, Shafiq F, et al
     Topical ivermectin treatment of rosacea changes the bacterial microbiome of the skin.
     J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02869.
     PubMed    
     
     
     
199. CHANG CT, Pathmarajah P, Allerup J, Jafry S, et al
     DDI-2: A Diverse Skin Condition Image Dataset Representing Self-Identified Asian Patients.
     J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02868.
     PubMed    
     
     
     
200. LI Z, Schneikert J, Bal G, Jin M, et al
     Intrinsic regulatory mechanisms protect human skin mast cells from excessive MRGPRX2 activation - paucity in LAD2 cells contributes to hyperresponsiveness of the mast cell line.
     J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02875.
     PubMed    
     
     
     
201. CUESTA-MARGOLLES G, Schlecht-Louf G, Bachelerie F
     ACKR3 in Skin Homeostasis, an Overlooked Player in the CXCR4/CXCL12 Axis.
     J Invest Dermatol. 2024 Oct 28:S0022-202X(24)02097.
     PubMed     Abstract available
     
     
     
202. GRICE EA, Brennan-Crispi D, Rodriguez N, Margolis DJ, et al
     Penn Academy for Skin Health (PASH): An Experiential Pipeline Program in Skin Biology and Dermatology for High-School Students.
     J Invest Dermatol. 2024 Oct 26:S0022-202X(24)02174.
     PubMed    
     
     
     
203. GELFAND JM
     Psoriasis: Disease Modification Today, Cure Tomorrow.
     J Invest Dermatol. 2024 Oct 24:S0022-202X(24)02190.
     PubMed    
     
     
     
204. LWIN SM, Azrielant S, He J, Griffiths CEM, et al
     Curing Psoriasis.
     J Invest Dermatol. 2024 Oct 22:S0022-202X(24)02161.
     PubMed     Abstract available
     
     
     
205. HONG SP, Batzorig U, Fernandez-Mendez C, Chen Y, et al
     HNRNPU is essential for proper murine skin development.
     J Invest Dermatol. 2024 Oct 9:S0022-202X(24)02179.
     PubMed    
     
     
     
206. EDER L, Caucheteux SM, Afiuni-Zadeh S, Croitoru D, et al
     Imaging Mass Cytometry in Psoriatic Disease reveals immune profile heterogeneity in skin and synovial tissue.
     J Invest Dermatol. 2024 Oct 9:S0022-202X(24)02180.
     PubMed     Abstract available
     
     
     
207. KUENZEL NA, Dobner J, Reichert D, Rossi A, et al
     Vdelta1 T cells integrated in full thickness skin equivalents: a model for the role of human skin-resident gammadeltaT cells.
     J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02173.
     PubMed     Abstract available
     
     
     
208. DAI X, Mizukami Y, Watanabe K, Tsuda T, et al
     Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing Nrf2 activation in human keratinocytes in vitro.
     J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02175.
     PubMed     Abstract available
     
     
     
209. ZHU X, Dai X, Chen W, Li Y, et al
     Chi3l1 Knockout Mitigates Chronic Itch and Cutaneous Inflammation in Mice.
     J Invest Dermatol. 2024 Oct 2:S0022-202X(24)02164.
     PubMed    
     
     
     
210. GURI-LAMCE I, Alrokh Y, Graham C, Maeshima R, et al
     Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro.
     J Invest Dermatol. 2024;144:2314-2317.
     PubMed    
     
     
     
211. WASSON CW, De Lorenzis E, Clavane EM, Ross RL, et al
     The beta-Secretase BACE1 Drives Fibroblast Activation in Systemic Sclerosis through the APP/beta-Catenin/Notch Signaling Axis.
     J Invest Dermatol. 2024;144:2197-2210.
     PubMed     Abstract available
     
     
     
212. WANG X, Yik-Lok Chung C, Yoshioka A, Hashimoto S, et al
     Chemo-Senolytic Therapeutic Potential against Angiosarcoma.
     J Invest Dermatol. 2024;144:2285-2297.
     PubMed     Abstract available
     
     
     
213. WANG Y, Zhao S, Zhang X, Xia D, et al
     Single-Cell Transcriptome Analysis Reveals Interaction between CCL19+ Inflammatory Keratinocytes and CCR7+ Dendritic Cells and B Cells in Pemphigus.
     J Invest Dermatol. 2024;144:2301-2305.
     PubMed    
     
     
     
214. SAYAR SB, Has C
     Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation.
     J Invest Dermatol. 2024;144:2221-2229.
     PubMed     Abstract available
     
     
     
215. NATTKEMPER LA, Kim BS, Yap QV, Hoon MA, et al
     Increased Systemic Levels of Centrally Acting B-Type Natriuretic Peptide Are Associated with Chronic Itch of Different Types.
     J Invest Dermatol. 2024;144:2267-2272.
     PubMed     Abstract available
     
     
     
216. INGOLD N, Seviiri M, Ong JS, Gordon S, et al
     Genetic Analysis of Perceived Youthfulness Reveals Differences in How Men's and Women's Age Is Assessed.
     J Invest Dermatol. 2024;144:2230-2239.
     PubMed     Abstract available
     
     
     
217. SCHNEEWEISS MC, Glynn RJ, Wyss R, Anand P, et al
     A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice.
     J Invest Dermatol. 2024 Oct 1:S0022-202X(24)02169.
     PubMed     Abstract available
     
     
     September 2024
218. MEANT A, Moussa O, Lebeau B, Goncalves C, et al
     Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel vulnerability in melanoma.
     J Invest Dermatol. 2024 Sep 30:S0022-202X(24)02160.
     PubMed    
     
     
     
219. BOGLE R, Patrick MT, Sreeskandarajan S, Gharaee-Kermani M, et al
     Profiling lncRNA in psoriatic skin using scRNA-seq.
     J Invest Dermatol. 2024 Sep 27:S0022-202X(24)02156.
     PubMed     Abstract available
     
     
     
220. FRISOLI ML, Ko WC, Martinez N, Afshari K, et al
     Single cell RNA-sequencing reveals molecular signatures that distinguish allergic from irritant contact dermatitis.
     J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02152.
     PubMed     Abstract available
     
     
     
221. DI GIROLAMO D, Di Iorio E, Missero C
     Molecular and Cellular Function of p63 in Skin Development and Genetic Diseases.
     J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02076.
     PubMed     Abstract available
     
     
     
222. SOLER-SAEZ I, Karz A, Hidalgo MR, Gomez-Cabanes B, et al
     Unveiling common transcriptomic features between melanoma brain metastases and neurodegenerative diseases.
     J Invest Dermatol. 2024 Sep 24:S0022-202X(24)02149.
     PubMed     Abstract available
     
     
     
223. BEYLOT-BARRY M, Staumont-Salle D
     Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.
     J Invest Dermatol. 2024 Sep 23:S0022-202X(24)02083.
     PubMed    
     
     
     
224. MATSUSHIMA Y, Hwang ST, Simon SI
     The Skinny on Dermal Fat and Its Anti-Inflammatory Role in Psoriasis.
     J Invest Dermatol. 2024 Sep 20:S0022-202X(24)02072.
     PubMed    
     
     
     
225. LIU Y, Andersen B, Gudjonsson JE, Plikus MV, et al
     Ancestral Diversity of Skin Reaches Single-Cell Resolution.
     J Invest Dermatol. 2024 Sep 20:S0022-202X(24)02071.
     PubMed    
     
     
     
226. CASSAGNE M, Galiacy S, Kychygina A, Chapotot E, et al
     Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
     J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
     PubMed     Abstract available
     
     
     
227. CHEN H, Chen Y, Zhou Y, Cao S, et al
     Optimizing Skin Surface Metabolomics: A Comprehensive Evaluation of Sampling Methods, Extraction Solvents, and Analytical Techniques.
     J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02105.
     PubMed     Abstract available
     
     
     
228. SAITO Y, Lotti R, Kimura H, Hasegawa A, et al
     Advancements in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: Utilizing Fas-Fas Ligand Inhibition to Target Cell Death Signaling Pathways for Practical Human Application.
     J Invest Dermatol. 2024 Sep 18:S0022-202X(24)02106.
     PubMed    
     
     
     
229. CHEN XB, Zheng YX, Guo TT, Xu F, et al
     Inhibition of epidermal isoleucyl-tRNA synthetase ameliorates psoriasis-like skin lesions via JAK2/STAT3/CXCL16 signaling pathway.
     J Invest Dermatol. 2024 Sep 16:S0022-202X(24)02095.
     PubMed    
     
     
     
230. JUNGWIRTH U, Walko G
     Boosting Skin Wound Healing by Agrin-Mediated YAP/TAZ Activation.
     J Invest Dermatol. 2024 Sep 14:S0022-202X(24)02070.
     PubMed    
     
     
     
231. CEPICA TB, Gupta R, Werth VP, Chong BF, et al
     Severity Scores for Cutaneous Lupus Erythematosus.
     J Invest Dermatol. 2024 Sep 14:S0022-202X(24)02074.
     PubMed     Abstract available
     
     
     
232. CHHABRA G, Ahmad N
     Mystery of Melanotransferrin in Melanoma.
     J Invest Dermatol. 2024 Sep 14:S0022-202X(24)01994.
     PubMed    
     
     
     
233. CHAI AC, Siegwart DJ, Wang RC
     Nucleic Acid Therapy for the Skin.
     J Invest Dermatol. 2024 Sep 13:S0022-202X(24)02062.
     PubMed     Abstract available
     
     
     
234. HAYRINEN M, Teppo HR, Vakeva L, Ranki A, et al
     Tumor RNA sequencing identifies a group of Mycosis Fungoides patients with failure of skin-directed therapies.
     J Invest Dermatol. 2024 Sep 6:S0022-202X(24)02084.
     PubMed    
     
     
     
235. BROOKS SG, Mahmoud RH, Lin RR, Fluhr JW, et al
     The Skin Acid Mantle: An Update on Skin pH.
     J Invest Dermatol. 2024 Sep 5:S0022-202X(24)01971.
     PubMed     Abstract available
     
     
     
236. GORESKI H, Ilic D, Flacher V, van den Bogaard E, et al
     NETSKINMODELS: A European Network for Skin Engineering and Modeling.
     J Invest Dermatol. 2024 Sep 3:S0022-202X(24)01897.
     PubMed    
     
     
     
237. PRIMIERO CA, Janda M, Soyer HP
     Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology.
     J Invest Dermatol. 2024 Sep 2:S0022-202X(24)01973.
     PubMed    
     
     
     
238. PEREZ OD, Tkaczyk ER, Petukhova L
     From the Microscopic Sweat Gland to Large Datasets: The Power of Quantitative Traits in Dermatology.
     J Invest Dermatol. 2024;144:1912-1914.
     PubMed    
     
     
     
239. POPP C, Miller W, Eide C, Tolar J, et al
     Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa.
     J Invest Dermatol. 2024;144:1943-1953.
     PubMed     Abstract available
     
     
     
240. SECHI A, Tosti A
     Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights.
     J Invest Dermatol. 2024;144:1915-1916.
     PubMed    
     
     
     
241. DEL CANO LR, South AP, O'Toole EA, Kelsell DP, et al
     A Role for Aquaporin-5 Variants in Regulation of the Actin Cytoskeleton in Non-Epidermolytic Palmoplantar Keratoderma.
     J Invest Dermatol. 2024;144:2092-2096.
     PubMed    
     
     
     
242. LE Y, Zhang J, Lin Y, Ren J, et al
     S100A9 Exacerbates the Inflammation in Rosacea through Toll-Like Receptor 4/MyD88/NF-kappaB Signaling Pathway.
     J Invest Dermatol. 2024;144:1985-1993.
     PubMed     Abstract available
     
     
     
243. LEISTI P, Huilaja L, Jokelainen J, Varpuluoma O, et al
     Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study.
     J Invest Dermatol. 2024;144:2078-2080.
     PubMed    
     
     
     
244. HWANG AS, Kechter JA, Li X, Hughes A, et al
     Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study.
     J Invest Dermatol. 2024;144:1994-2001.
     PubMed     Abstract available
     
     
     
245. LEE JY, Lim HJ, Kim SH, Lee GJ, et al
     Decreased CD19(+)CD24(hi)CD38(hi) Regulatory B Cells in Alopecia Areata.
     J Invest Dermatol. 2024;144:2080-2083.
     PubMed    
     
     
     August 2024
246. PARK K, Shin KO, Kim YI, Nielsen-Scott AL, et al
     Sphingosine-1-phosphate-cathelicidin axis plays a pivotal role in the development of cutaneous squamous cell carcinoma.
     J Invest Dermatol. 2024 Aug 30:S0022-202X(24)02069.
     PubMed     Abstract available
     
     
     
247. FAWAY E, Poirier W, Marechal F, Poumay Y, et al
     Expression of fungal and host markers in models of dermatophytosis on mice and human epidermis.
     J Invest Dermatol. 2024 Aug 30:S0022-202X(24)02073.
     PubMed     Abstract available
     
     
     
248. PARIKH S, Levy C
     The Hungry Side of Skin.
     J Invest Dermatol. 2024 Aug 29:S0022-202X(24)00448.
     PubMed    
     
     
     
249. LU KQ, Gianneschi NC
     Synthetic Melanin as a Topical Agent for Accelerated Skin Repair.
     J Invest Dermatol. 2024 Aug 28:S0022-202X(24)01981.
     PubMed    
     
     
     
250. HARMON RM, Ayers JL, McCarthy EF, Kowalczyk AP, et al
     Pumping the Breaks on Acantholytic Skin Disorders: Targeting Calcium Pumps, Desmosomes, and Downstream Signaling in Darier, Hailey-Hailey, and Grover Disease.
     J Invest Dermatol. 2024 Aug 28:S0022-202X(24)01925.
     PubMed     Abstract available
     
     
     
251. CHEUNG ST, Do Y, Kim E, Rella A, et al
     G Protein-Coupled Receptors in Skin Aging.
     J Invest Dermatol. 2024 Aug 25:S0022-202X(24)01919.
     PubMed     Abstract available
     
     
     
252. GOLDSTEIN NB, Berk Z, Tomb L, Hu J, et al
     Phosphodiesterase-4 inhibitors increase pigment cells proliferation and melanization in cultured melanocytes and within a 3D skin equivalent model.
     J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02055.
     PubMed     Abstract available
     
     
     
253. TIRTIAUX B, Ianiri G, De Glas V, Denil E, et al
     Invasion of human epidermis by Malassezia furfur is strain dependent.
     J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02061.
     PubMed    
     
     
     
254. RUTJES C, Mothershaw A, D'Alessandro BM, Primiero CA, et al
     Combining Automated Lesion Risk And Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study.
     J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02060.
     PubMed    
     
     
     
255. DEACON DC, Stubben C, Marcacci E, Stone CJ, et al
     Classification of Cutaneous Melanoma and Melanocytic Nevi with microRNA Ratios is Preserved in the Acral Melanoma Subtype.
     J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02063.
     PubMed    
     
     
     
256. QIU Y, Jiang W, Feng D, Yu Y, et al
     Resolving 3D genomic landscape of CD4+ T cells in the peripheral blood of patients with psoriasis.
     J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02064.
     PubMed     Abstract available
     
     
     
257. KUMARAN G, Carroll L, Muirhead N, Bottomley MJ, et al
     How Can Spatial Transcriptomic Profiling Advance Our Understanding of Skin Diseases?
     J Invest Dermatol. 2024 Aug 21:S0022-202X(24)01926.
     PubMed     Abstract available
     
     
     
258. DE SILVA K, Yan J
     Immune Landscape within Cutaneous Lesions of Human Bullous Pemphigoid.
     J Invest Dermatol. 2024 Aug 21:S0022-202X(24)00364.
     PubMed    
     
     
     
259. ROOP DR, Krieg T, Werner S, Yuspa S, et al
     Montagna Symposium on the Biology of Skin 70(th) Anniversary: Visualizing the Future!
     J Invest Dermatol. 2024 Aug 20:S0022-202X(24)00305.
     PubMed    
     
     
     
260. SCHRADER AMR, van Engeland J, Willemze R, Vermaat JSP, et al
     DETECTION OF CIRCULATING TUMOR DNA FOR DISEASE MONITORING IN PATIENTS WITH PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG TYPE.
     J Invest Dermatol. 2024 Aug 16:S0022-202X(24)01996.
     PubMed    
     
     
     
261. GOMES MLNP, Krijnen PAJ, Middelkoop E, Niessen HWM, et al
     Fetal Skin Wound Healing: Key Extracellular Matrix Components and Regulators in Scarless Healing.
     J Invest Dermatol. 2024 Aug 16:S0022-202X(24)01863.
     PubMed     Abstract available
     
     
     
262. DE PESSEMIER B, Lopez CD, Taelman S, Verdonck M, et al
     COMPARATIVE WHOLE METAGENOME ANALYSIS IN LESIONAL AND NON-LESIONAL SCALP AREAS OF PSORIASIS CAPITIS PATIENTS AND HEALTHY INDIVIDUALS.
     J Invest Dermatol. 2024 Aug 9:S0022-202X(24)01984.
     PubMed     Abstract available
     
     
     
263. QUILEZ C, Bebiano LB, Jones E, Maver U, et al
     Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments.
     J Invest Dermatol. 2024 Aug 9:S0022-202X(24)01499.
     PubMed     Abstract available
     
     
     
264. CHOI D, Bakhtiari M, Pilcher W, Huang C, et al
     Single-cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in non-Hispanic Blacks.
     J Invest Dermatol. 2024 Aug 8:S0022-202X(24)01979.
     PubMed     Abstract available
     
     
     
265. SIMMONS J, Gallo RL
     The Central Roles of Keratinocytes in Coordinating Skin Immunity.
     J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01882.
     PubMed     Abstract available
     
     
     
266. ADAWI W, Ro C, Scoville D, Liang Y, et al
     The epithelial transcriptome of hidradenitis suppurativa tunnels is more similar to cutaneous squamous cell carcinoma than to benign infundibular cysts.
     J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01980.
     PubMed    
     
     
     
267. SUH JH, Lee Y, Jin SP, Kim EJ, et al
     Adiponectin prevents skin inflammation in rosacea by suppressing S6 phosphorylation in keratinocytes.
     J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01982.
     PubMed     Abstract available
     
     
     
268. JONES MR, Jones J, Pandu P, Liu C, et al
     Neurturin Growth Factor Enhances the Acute Cytokine Response of Inflamed Skin.
     J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01978.
     PubMed     Abstract available
     
     
     
269. LEE CN, Hong YK, Cheng HC, Chi WY, et al
     Mechanical Stretch Exacerbates Imiquimod-Induced Dermatitis Associated with Increased IL-1beta and IL-6 Production.
     J Invest Dermatol. 2024 Aug 3:S0022-202X(24)01977.
     PubMed    
     
     
     
270. OGAWA-MOMOHARA M, Vazquez T, Chin F, Sharma M, et al
     Multiplexed mass cytometry of cutaneous lupus erythematosus and dermatomyositis skin: An in-depth, B cell directed immunoprofile.
     J Invest Dermatol. 2024 Aug 2:S0022-202X(24)01969.
     PubMed    
     
     
     
271. PARK S, Bell A, Gibson R, Masson R, et al
     Advances in Hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances 2023.
     J Invest Dermatol. 2024;144:1681-1684.
     PubMed    
     
     
     
272. SCHELL SL, Nelson AM
     Setting the Stage for Standardized Reporting of Clinical and Demographic Information in Laboratory-Based Studies of Hidradenitis Suppurativa.
     J Invest Dermatol. 2024;144:1689-1695.
     PubMed     Abstract available
     
     
     
273. PAYNE AS, Manfredo Vieira S
     Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier.
     J Invest Dermatol. 2024;144:1667-1670.
     PubMed    
     
     
     
274. WELLER RB
     Sunlight: Time for a Rethink?
     J Invest Dermatol. 2024;144:1724-1732.
     PubMed     Abstract available
     
     
     
275. MACRAE VE
     The Adaptive Immune System: A New Pseudoxanthoma Elasticum Protagonist?
     J Invest Dermatol. 2024;144:1670-1672.
     PubMed    
     
     
     
276. MURRELL DF, Caux F, Patsatsi A, Hagino O, et al
     Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study.
     J Invest Dermatol. 2024;144:1762-1771.
     PubMed     Abstract available
     
     
     
277. WU Y, Yang Y, Lin Y, Ding Y, et al
     Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star.
     J Invest Dermatol. 2024;144:1696-1706.
     PubMed     Abstract available
     
     
     
278. BRAMPTON C, Pomozi V, Le Corre Y, Zoll J, et al
     Bone Marrow-Derived ABCC6 Is an Essential Regulator of Ectopic Calcification In Pseudoxanthoma Elasticum.
     J Invest Dermatol. 2024;144:1772-1783.
     PubMed     Abstract available
     
     
     
279. MALIGA Z, Kim DY, Bui AN, Lin JR, et al
     Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study.
     J Invest Dermatol. 2024;144:1887-1890.
     PubMed    
     
     
     
280. LI Y, Chen W, Zhu X, Mei H, et al
     Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.
     J Invest Dermatol. 2024;144:1829-1842.
     PubMed     Abstract available
     
     
     
281. JAIRATH NK, Qiblawi S, Jeha GM, Pahalyants V, et al
     Leveraging OpenAI's Advanced Data Analysis Tool in Dermatology: Opportunities and Challenges.
     J Invest Dermatol. 2024;144:1879-1882.
     PubMed    
     
     
     
282. VIKAR S, Szilveszter KP, Koszoru K, Sardy M, et al
     The Syk Inhibitor Entospletinib Abolishes Dermal-Epidermal Separation in a Fully Human Ex Vivo Model of Bullous Pemphigoid.
     J Invest Dermatol. 2024;144:1733-1742.
     PubMed     Abstract available
     
     
     
283. WANG D, Chen W, Wang Y, Yu J, et al
     Genome-Wide Meta-Analysis Identifies 11 Susceptibility Variants of Vitiligo in the Chinese Han Population.
     J Invest Dermatol. 2024;144:1843-1849.
     PubMed     Abstract available
     
     
     July 2024
284. SON DO, Benitez R, Diao L, Hinz B, et al
     How to Keep Myofibroblasts under Control: Culture of Mouse Skin Fibroblasts on Soft Substrates.
     J Invest Dermatol. 2024 Jul 29:S0022-202X(24)01885.
     PubMed     Abstract available
     
     
     
285. LOW E, Smith LA, Miwa S, Fielder E, et al
     Senescent dermal fibroblasts decrease stemness in basal keratinocytes in a bioengineered model of human full thickness skin.
     J Invest Dermatol. 2024 Jul 22:S0022-202X(24)01916.
     PubMed    
     
     
     
286. GIOVANNINI S, Weibel L, Schittek B, Sinnberg T, et al
     Skin cancer induction by the antimycotic drug voriconazole is caused by impaired DNA damage detection due to chromatin compaction.
     J Invest Dermatol. 2024 Jul 22:S0022-202X(24)01920.
     PubMed     Abstract available
     
     
     
287. GAUDEL C, Pisibon C, Soysouvanh F, Giuliano S, et al
     Loss of LYN is frequent in targeted-therapy resistant melanoma cells and favors metastatic properties.
     J Invest Dermatol. 2024 Jul 19:S0022-202X(24)01913.
     PubMed    
     
     
     
288. MARNEROS AG
     Aplasia Cutis Congenita Pathomechanisms Reveal Key Regulators of Skin and Skin Appendage Morphogenesis.
     J Invest Dermatol. 2024 Jul 17:S0022-202X(24)01730.
     PubMed     Abstract available
     
     
     
289. MCDONALD A, Karnik R, Campbell V, Davis J, et al
     Interleukin 1 Receptor-Associated Kinase 4 is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers.
     J Invest Dermatol. 2024 Jul 17:S0022-202X(24)01899.
     PubMed     Abstract available
     
     
     
290. MAMMADOV Y, Austin J, Shipowick T, Veldman K, et al
     A European Roundtable "Addressing Under-Prioritized Skin Diseases: Policy Responses to High-Burden Conditions", February 6, 2024.
     J Invest Dermatol. 2024 Jul 15:S0022-202X(24)01736.
     PubMed    
     
     
     
291. HASSEL JC, Stanhope S, Greenshields-Watson A, Machiraju D, et al
     Tebentafusp induces a T cell driven rash in melanocyte-bearing skin as an adverse event consistent with the mechanism of action.
     J Invest Dermatol. 2024 Jul 15:S0022-202X(24)01886.
     PubMed     Abstract available
     
     
     
292. FARAG A, Visvanathan S, Bachelez H, Morita A, et al
     Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterisation of Flare Treatment in EFFISAYIL(R) 1.
     J Invest Dermatol. 2024 Jul 12:S0022-202X(24)01888.
     PubMed     Abstract available
     
     
     
293. KADIN ME, Hamilton RG
     Breaking the Vicious Cycle of Staphylococcal aureus Skin Colonization and Progression of Cutaneous T-Cell Lymphoma.
     J Invest Dermatol. 2024 Jul 12:S0022-202X(24)01738.
     PubMed    
     
     
     
294. TRAUPE H
     Autosomal Dominant Lamellar Ichthyosis Keeps Surprising Us.
     J Invest Dermatol. 2024 Jul 11:S0022-202X(24)00446.
     PubMed    
     
     
     
295. SLOMINSKI AT, Kim TK, Janjetovic Z, Slominski RM, et al
     Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin.
     J Invest Dermatol. 2024 Jul 11:S0022-202X(24)00386.
     PubMed     Abstract available
     
     
     
296. LATONI DI, Geller A, Semenov YR, Ji Z, et al
     Geotemporal analysis of melanoma incidence and mortality identifies distinct clusters of trends within the United States between 2001-2019.
     J Invest Dermatol. 2024 Jul 7:S0022-202X(24)01874.
     PubMed     Abstract available
     
     
     
297. MARONESE CA, Valenti M, Moltrasio C, Romagnuolo M, et al
     Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options.
     J Invest Dermatol. 2024 Jul 2:S0022-202X(24)01731.
     PubMed     Abstract available
     
     
     
298. GUI H, Omiye JA, Chang CT, Daneshjou R, et al
     The Promises and Perils of Foundation Models in Dermatology.
     J Invest Dermatol. 2024;144:1440-1448.
     PubMed     Abstract available
     
     
     
299. HAGERTY JR, Nambisan A, Stanley RJ, Stoecker WV, et al
     Fusion of Deep Learning with Conventional Imaging Processing: Does It Bring Artificial Intelligence Closer to the Clinic?
     J Invest Dermatol. 2024;144:1424-1427.
     PubMed    
     
     
     
300. TAKAHASHI R, Kinoshita-Ise M, Yamazaki Y, Fukuyama M, et al
     Increase in CD8(+) Effector Memory T Cells Re-Expressing CD45RA Correlates with Intractability of Severe Alopecia Areata.
     J Invest Dermatol. 2024;144:1654-1657.
     PubMed    
     
     
     
301. PATEL JR, Joel MZ, Lee KK, Kambala A, et al
     Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis.
     J Invest Dermatol. 2024;144:1568-1578.
     PubMed     Abstract available
     
     
     
302. CONDORELLI AG, Nobili R, Muglia A, Scarpelli G, et al
     Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa.
     J Invest Dermatol. 2024;144:1522-1533.
     PubMed     Abstract available
     
     
     
303. SEHEULT JN, Weybright MJ, Jevremovic D, Shi M, et al
     Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features.
     J Invest Dermatol. 2024;144:1590-1599.
     PubMed     Abstract available
     
     
     
304. HONG YK, Hwang DY, Yang CC, Cheng SM, et al
     Profibrotic Subsets of SPP1(+) Macrophages and POSTN(+) Fibroblasts Contribute to Fibrotic Scarring in Acne Keloidalis.
     J Invest Dermatol. 2024;144:1491-1504.
     PubMed     Abstract available
     
     
     
305. DING H, Zhou L, Zhou J, Feng J, et al
     Peripheral Mechanisms of Mechanical Itch.
     J Invest Dermatol. 2024;144:1449-1453.
     PubMed     Abstract available
     
     
     
306. TANIGUCHI C, Narisada A, Ohshima Y, Inagaki K, et al
     Interactive Effects of Sex and Smoking on Palmoplantar Pustulosis: Japanese Healthcare Claim Database Study.
     J Invest Dermatol. 2024;144:1651-1653.
     PubMed    
     
     
     June 2024
307. GU J, Zhou Z, Xu S, Pan W, et al
     Topical Application of Nitrate Ameliorates Skin Fibrosis by Regulating ST2(+)CD4(+) T Cells in Systemic Sclerosis Mouse Model.
     J Invest Dermatol. 2024 Jun 28:S0022-202X(24)01870.
     PubMed     Abstract available
     
     
     
308. LAVIN L, Dusza S, Geller S
     Cutaneous T-cell lymphoma following dupilumab use - A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).
     J Invest Dermatol. 2024 Jun 28:S0022-202X(24)01865.
     PubMed    
     
     
     
309. CLAUWAERT V, Verhaeghe E, De Schepper S, Haspeslagh M, et al
     Clinicopathologically Defined Naevus Subtypes and Melanoma Risk.
     J Invest Dermatol. 2024 Jun 26:S0022-202X(24)01868.
     PubMed     Abstract available
     
     
     
310. BLAUVELT A, Gordon KB, Langley RG, Branigan PJ, et al
     Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
     J Invest Dermatol. 2024 Jun 25:S0022-202X(24)01737.
     PubMed    
     
     
     
311. SHIOHARA T, Mizukawa Y
     The Neglected Beneficial Role of Sweat in Atopic Dermatitis Is Spotlighted at Last.
     J Invest Dermatol. 2024 Jun 22:S0022-202X(24)00381.
     PubMed    
     
     
     
312. DENG Z, Yang Y, Suzuki K
     Federated Active Learning Framework for Ef fi cient Annotation Strategy in Skin-lesion Classification.
     J Invest Dermatol. 2024 Jun 21:S0022-202X(24)01858.
     PubMed     Abstract available
     
     
     
313. JANDOVA J, Wondrak GT
     Melanotransferrin (MELTF, MFI2, CD228) expression attenuates malignant melanoma progression in the A375-Luc2 murine metastasis model and human patients.
     J Invest Dermatol. 2024 Jun 21:S0022-202X(24)01864.
     PubMed    
     
     
     
314. KAO YC, Stark MS
     Challenging the Lymph Node Progression Model of Melanoma.
     J Invest Dermatol. 2024 Jun 20:S0022-202X(24)00385.
     PubMed    
     
     
     
315. YANG B, Ma X, Li J
     Skin transcriptome analysis reveals potential molecular mechanisms of S100A9 in exacerbating the inflammation in rosacea.
     J Invest Dermatol. 2024 Jun 20:S0022-202X(24)01859.
     PubMed    
     
     
     
316. GANIER C, Callewaert C, Matos TR, Sonkoly E, et al
     Young ESDR: Engaging and Nurturing the Next-Generation Skin Research Community.
     J Invest Dermatol. 2024 Jun 19:S0022-202X(24)00382.
     PubMed    
     
     
     
317. PEREDA J, Milde Khatib C, Kezic S, Christensen MO, et al
     A Review of Atomic-Force Microscopy in Skin Barrier Function Assessment.
     J Invest Dermatol. 2024 Jun 18:S0022-202X(24)00357.
     PubMed     Abstract available
     
     
     
318. OLSEN CM, Pandeya N, Miranda-Filho A, Rosenberg PS, et al
     Does sex matter? Temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity.
     J Invest Dermatol. 2024 Jun 17:S0022-202X(24)01500.
     PubMed     Abstract available
     
     
     
319. CVAMMEN W, Rider SD Jr, Kemp MG
     Analysis of circadian clock gene expression in epidermal human skin indicates that body location impacts rhythm amplitude.
     J Invest Dermatol. 2024 Jun 15:S0022-202X(24)01497.
     PubMed    
     
     
     
320. BAO L, Perez White BE, Chang RC, Li J, et al
     FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents.
     J Invest Dermatol. 2024 Jun 15:S0022-202X(24)01504.
     PubMed    
     
     
     
321. TILIGADA E, Levi-Schaffer F
     Infiltrating Basophils Tune Injured Skin Barrier Recovery.
     J Invest Dermatol. 2024 Jun 14:S0022-202X(24)00438.
     PubMed    
     
     
     
322. MA X, Zhao H, Song JK, Zhang Z, et al
     Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.
     J Invest Dermatol. 2024 Jun 13:S0022-202X(24)01735.
     PubMed     Abstract available
     
     
     
323. LAMBERT KA, Clements CM, Mukherjee N, Pacheco TR, et al
     SASH1 S519N variant links skin hyperpigmentation and premature hair graying to dysfunction of melanocyte lineage.
     J Invest Dermatol. 2024 Jun 5:S0022-202X(24)00393.
     PubMed     Abstract available
     
     
     
324. VORSTANDLECHNER V, Mildner M
     Much More Than Just Diabetes: The Pivotal Role of Dipeptidyl-Peptidase 4 in Skin Fibrosis.
     J Invest Dermatol. 2024 Jun 4:S0022-202X(24)00375.
     PubMed    
     
     
     
325. CHEN C, Yang J, Shang R, Tang Y, et al
     Orchestration of macrophage polarization dynamics by fibroblast-secreted exosomes during skin wound healing.
     J Invest Dermatol. 2024 Jun 3:S0022-202X(24)00445.
     PubMed     Abstract available
     
     
     
326. SHEN S, Sobczyk MK, Paternoster L, Brown SJ, et al
     From GWASs toward Mechanistic Understanding with Case Studies in Dermatogenetics.
     J Invest Dermatol. 2024;144:1189-1199.
     PubMed     Abstract available
     
     
     
327. LONG GR, Kurdian AI, Atwood SX
     Applying Multiomics to Basosquamous Carcinoma.
     J Invest Dermatol. 2024;144:1181-1183.
     PubMed    
     
     
     
328. SONG WB, Garshick MS, Barbieri JS, Shin DB, et al
     A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.
     J Invest Dermatol. 2024;144:1405-1409.
     PubMed    
     
     
     
329. WEN D, Hunjan M, Bardhan A, Harper N, et al
     Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity.
     J Invest Dermatol. 2024;144:1334-1343.
     PubMed     Abstract available
     
     
     
330. JUSSILA AR, Haensel D, Gaddam S, Oro AE, et al
     Acquisition of Drug Resistance in Basal Cell Nevus Syndrome Tumors through Basal to Squamous Cell Carcinoma Transition.
     J Invest Dermatol. 2024;144:1368-1377.
     PubMed     Abstract available
     
     
     
331. ZHU H, Luo H, Skaug B, Tabib T, et al
     Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features.
     J Invest Dermatol. 2024;144:1251-1261.
     PubMed     Abstract available
     
     
     
332. ELHANI I, Riller Q, Boursier G, Hentgen V, et al
     A20 Haploinsufficiency: A Systematic Review of 177 Cases.
     J Invest Dermatol. 2024;144:1282-1294.
     PubMed     Abstract available
     
     
     
333. KAMAL K, Xia E, Li SJ, Alavi A, et al
     Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.
     J Invest Dermatol. 2024;144:1295-1300.
     PubMed     Abstract available
     
     
     
334. ISHII K, Ishii N, Ishiko A, Hashimoto T, et al
     Pemphigus Autoantibodies to Desmocollin 3 but Not to Desmocollin 1 Directly Block Heterophilic Desmoglein/Desmocollin Transinteraction.
     J Invest Dermatol. 2024;144:1394-1397.
     PubMed    
     
     
     
335. WANG XY, Jia QN, Wu MY, Liu MJ, et al
     Comparing the Efficacy of Updated Treatment Choices for Prurigo Nodularis: A Network Meta-Analysis.
     J Invest Dermatol. 2024;144:1409-1412.
     PubMed    
     
     
     
336. DURAND MA, Drouin A, Bachiri K, Durand L, et al
     Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma.
     J Invest Dermatol. 2024;144:1398-1401.
     PubMed    
     
     
     
337. BERTHAULT C, Gaucher S, Gouin O, Schmitt A, et al
     Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
     J Invest Dermatol. 2024;144:1322-1333.
     PubMed     Abstract available
     
     
     
338. LANGBROEK GB, Stor MLE, Janssen V, de Haan A, et al
     Characterization of Patient-Derived GNAQ Mutated Endothelial Cells from Capillary Malformations.
     J Invest Dermatol. 2024;144:1378-1388.
     PubMed     Abstract available
     
     
     May 2024
339. NARANPANAWA N, Jayasinghe D, Sturm RA, Betz-Stablein B, et al
     Automated Detection of Pigmented Iris Freckles using a Deep Neural Network for Cutaneous Melanoma Risk.
     J Invest Dermatol. 2024 May 30:S0022-202X(24)00444.
     PubMed    
     
     
     
340. SONG Z, Gao M, Li T, Zhang Y, et al
     TRPV3-activated PARP1/AIFM1/MIF axis through oxidative stress contributes to atopic dermatitis.
     J Invest Dermatol. 2024 May 30:S0022-202X(24)00384.
     PubMed     Abstract available
     
     
     
341. YU LIN MO, Sampath D, Bosykh DA, Wang C, et al
     YAP/TAZ Drive Agrin-Matrix Metalloproteinase-12 Mediated Diabetic Skin Wound Healing.
     J Invest Dermatol. 2024 May 27:S0022-202X(24)00391.
     PubMed     Abstract available
     
     
     
342. BEKE G, Lendvai A, Hollosi E, Braun N, et al
     Topically applied N,N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release.
     J Invest Dermatol. 2024 May 24:S0022-202X(24)00383.
     PubMed    
     
     
     
343. LEE MJ, Hammouda MB, Miao W, Okafor A, et al
     UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation.
     J Invest Dermatol. 2024 May 23:S0022-202X(24)00376.
     PubMed     Abstract available
     
     
     
344. HEIKKILA A, Sliz E, Huilaja L, Reis K, et al
     GENETIC STUDY OF PSORIASIS HIGHLIGHTS ITS CLOSE LINK WITH SOCIO-ECONOMIC STATUS AND AFFECTIVE SYMPTOMS.
     J Invest Dermatol. 2024 May 17:S0022-202X(24)00358.
     PubMed     Abstract available
     
     
     
345. ZENG Z, Vadivel CK, Gluud M, Namini MRJ, et al
     Keratinocytes present Staphylococcus aureus enterotoxins and promote malignant and non-malignant T cell proliferation in cutaneous T cell lymphoma.
     J Invest Dermatol. 2024 May 16:S0022-202X(24)00377.
     PubMed     Abstract available
     
     
     
346. GREENSPAN LJ, Cisneros I, Weinstein BM
     Dermal Dive: An Overview of Cutaneous Wounding Techniques in Zebrafish.
     J Invest Dermatol. 2024 May 15:S0022-202X(24)00309.
     PubMed     Abstract available
     
     
     
347. BORZUTZKY A, Cabalin C
     From Thin to Thick: Weight Gain in Children Feeds the Risk of Atopic Dermatitis.
     J Invest Dermatol. 2024 May 14:S0022-202X(24)00281.
     PubMed    
     
     
     
348. HAYES J, Higgins CA
     Plantar Skin: A Callus Design?
     J Invest Dermatol. 2024 May 13:S0022-202X(24)00273.
     PubMed    
     
     
     
349. XIAO W, Sha K, Wang M, Tan Z, et al
     SERPINB3/B4 is Increased in Psoriasis and Rosacea Lesions and has Pro-inflammatory Effects in Mouse Models of these Diseases.
     J Invest Dermatol. 2024 May 10:S0022-202X(24)00367.
     PubMed     Abstract available
     
     
     
350. GORDON ER, Fahmy LM, Trager MH, Adeuyan O, et al
     From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation.
     J Invest Dermatol. 2024 May 4:S0022-202X(24)00262.
     PubMed     Abstract available
     
     
     
351. SCHMUTH M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, et al
     Skin Barrier in Atopic Dermatitis.
     J Invest Dermatol. 2024;144:989-1000.
     PubMed     Abstract available
     
     
     
352. BROWN SJ, Gudjonsson JE
     Halting the Vicious Cycle of Atopic Dermatitis: Empowered by Scientific Understanding.
     J Invest Dermatol. 2024;144:917-918.
     PubMed    
     
     
     
353. STEINHOFF M, Buddenkotte J
     Flushing New Light on Rosacea.
     J Invest Dermatol. 2024;144:934-935.
     PubMed    
     
     
     
354. DARCHINI-MARAGHEH E, Sinclair R
     Comment on Xia et al "Outcome Measures for Alopecia Areata".
     J Invest Dermatol. 2024;144:1165-1166.
     PubMed    
     
     
     
355. SURBER C, Osterwalder U
     Response to "Sunscreens: Misconceptions and Misinformation".
     J Invest Dermatol. 2024;144:1175-1177.
     PubMed    
     
     
     
356. KIM SR, Yu DA, Cho SI, Kwon O, et al
     Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease.
     J Invest Dermatol. 2024;144:1166-1169.
     PubMed    
     
     
     
357. NATHANS JF, Ayers JL, Shendure J, Simpson CL, et al
     Genetic Tools for Cell Lineage Tracing and Profiling Developmental Trajectories in the Skin.
     J Invest Dermatol. 2024;144:936-949.
     PubMed     Abstract available
     
     
     April 2024
358. MONTANO E, Tapia A, Howell MD, Ostojic J, et al
     Comparison of Tape-Stripping Platforms as Non-Invasive Solutions for Skin Biomarker Discovery.
     J Invest Dermatol. 2024 Apr 30:S0022-202X(24)00356.
     PubMed    
     
     
     
359. JOHNSTON LA, Nagalla RR, Li M, Whitley SK, et al
     IL-17 Control of Cutaneous Immune Homeostasis.
     J Invest Dermatol. 2024 Apr 26:S0022-202X(23)03191.
     PubMed     Abstract available
     
     
     
360. GANIER C
     Unlocking Skin's Symphony: Single-Cell and Spatial Transcriptomics Reveal the Harmonious Interplay among Diverse Cell Populations.
     J Invest Dermatol. 2024 Apr 26:S0022-202X(24)00282.
     PubMed    
     
     
     
361. XIONG S, Liu F, Sun J, Gao S, et al
     Abrogation of USP9X is a potential strategy to decrease PEG10 levels and impede tumor progression in cutaneous T-cell lymphoma.
     J Invest Dermatol. 2024 Apr 25:S0022-202X(24)00307.
     PubMed     Abstract available
     
     
     
362. PASANEN A, Sliz E, Huilaja L, Reimann E, et al
     Identifying atopic dermatitis risk loci in 1,094,060 individuals with sub analysis of disease severity and onset.
     J Invest Dermatol. 2024 Apr 23:S0022-202X(24)00285.
     PubMed     Abstract available
     
     
     
363. KIM SR, Koh SJ, Park H
     Childhood Obesity, Weight Change, and Pediatric Immune-Mediated Skin Diseases.
     J Invest Dermatol. 2024 Apr 20:S0022-202X(24)00257.
     PubMed     Abstract available
     
     
     
364. CHEN M, Li J, Ding Y, Zhang C, et al
     Skin Aging Research Enters a New Era in China.
     J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00266.
     PubMed    
     
     
     
365. VAN DEN BRINK NJM, Pardow F, Meesters LD, van Vlijmen-Willems I, et al
     Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.
     J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00293.
     PubMed     Abstract available
     
     
     
366. KOMLOSI K, Glocker C, Hsu-Rehder HH, Alter S, et al
     Autosomal dominant lamellar ichthyosis due to a missense mutation in the gene NKPD1.
     J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00303.
     PubMed     Abstract available
     
     
     
367. EGU DT, Schmitt T, Ernst N, Ludwig RJ, et al
     EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects Against Pemphigus Vulgaris IgG-Induced Acantholysis in Human Epidermis.
     J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00301.
     PubMed     Abstract available
     
     
     
368. KOHL LM, Sumpter TL
     The ART(N) of Keratinocytes Leading Neurons into the Skin.
     J Invest Dermatol. 2024 Apr 10:S0022-202X(24)00191.
     PubMed    
     
     
     
369. SAKAGUCHI S, Tsutsumi M, Akita S, Konyo M, et al
     Human Merkel cells as the initiator of mechanotransduction in skin: Linking the animal model to humans.
     J Invest Dermatol. 2024 Apr 10:S0022-202X(24)00278.
     PubMed    
     
     
     
370. KHADKA VD, Markey L, Boucher M, Lieberman TD, et al
     Commensal skin bacteria exacerbate inflammation and delay skin barrier repair.
     J Invest Dermatol. 2024 Apr 9:S0022-202X(24)00277.
     PubMed     Abstract available
     
     
     
371. RANDERSON-MOOR J, Davies J, Harland M, Nsengimana J, et al
     Systemic inflammation, the peripheral blood transcriptome and primary melanoma.
     J Invest Dermatol. 2024 Apr 5:S0022-202X(24)00275.
     PubMed     Abstract available
     
     
     
372. BEZROOKOVE V, Kianian S, McGeever L, Jones R, et al
     The molecular evolution of melanoma distant metastases.
     J Invest Dermatol. 2024 Apr 4:S0022-202X(24)00271.
     PubMed     Abstract available
     
     
     
373. GONG P, Ding Y, Li W, Yang J, et al
     Neutrophil-driven M2-like macrophages are critical for skin fibrosis in a systemic sclerosis model.
     J Invest Dermatol. 2024 Apr 3:S0022-202X(24)00274.
     PubMed     Abstract available
     
     
     
374. LIU H, Wang N, Yang R, Luan J, et al
     E3 ubiquitin ligase NEDD4L negatively regulates skin tumorigenesis by inhibiting of IL-6/GP130 signaling pathway.
     J Invest Dermatol. 2024 Apr 3:S0022-202X(24)00272.
     PubMed     Abstract available
     
     
     
375. PALLER AS, Scharschmidt TC, Kezic S, Irvine AD, et al
     Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area.
     J Invest Dermatol. 2024 Apr 2:S0022-202X(24)00186.
     PubMed     Abstract available
     
     
     
376. O'TOOLE EA, Kelsell DP, Caterina MJ, de Brito M, et al
     Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches.
     J Invest Dermatol. 2024;144:748-754.
     PubMed     Abstract available
     
     
     
377. SHIU J, Lentsch G, Polleys CM, Mobasher P, et al
     Noninvasive Imaging Techniques for Monitoring Cellular Response to Treatment in Stable Vitiligo.
     J Invest Dermatol. 2024;144:912-915.
     PubMed    
     
     
     
378. GUNTER SJ, Kim EJ
     Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sezary Syndrome.
     J Invest Dermatol. 2024;144:855-861.
     PubMed     Abstract available
     
     
     
379. FLORA A, Jepsen R, Pham J, Frew JW, et al
     Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial.
     J Invest Dermatol. 2024;144:786-793.
     PubMed     Abstract available
     
     
     
380. KNOPFEL N, Zecchin D, Richardson H, Polubothu S, et al
     GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.
     J Invest Dermatol. 2024;144:820-832.
     PubMed     Abstract available
     
     
     March 2024
381. GIUSTINIANI J, Anh Ta V, Belkhelouat S, Battistella M, et al
     Targeting TGF-beta activation in cutaneous T-cell lymphomas.
     J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00259.
     PubMed    
     
     
     
382. BATZORIG U, Chen Y, Liu Y, Fernandez-Mendez C, et al
     The SWI/SNF subunit ARID1A mediates neutrophil associated skin inflammatory responses.
     J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00211.
     PubMed    
     
     
     
383. XIA E, Gaurav A, Noe MH, Mostaghimi A, et al
     Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.
     J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
     PubMed    
     
     
     
384. SAHEB KASHAF S, Kong HH
     Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.
     J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00082.
     PubMed     Abstract available
     
     
     
385. ARADI P, Kovacs G, Kemecsei E, Molnar K, et al
     Lymphatics-dependent modulation of the sensitization and elicitation phases of contact hypersensitivity.
     J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00261.
     PubMed     Abstract available
     
     
     
386. CHIU HY, Lin YJ, Huang YH
     Dipeptidyl peptidase-4 inhibitors and the risk of chronic inflammatory skin diseases in type 2 diabetes mellitus in Taiwan: a nationwide population-based cohort study.
     J Invest Dermatol. 2024 Mar 25:S0022-202X(24)00214.
     PubMed    
     
     
     
387. RUAN Y, Xu C, Zhang T, Zhu L, et al
     Single-cell profiling unveils the inflammatory heterogeneity within cutaneous lesions of bullous pemphigoid.
     J Invest Dermatol. 2024 Mar 25:S0022-202X(24)00209.
     PubMed     Abstract available
     
     
     
388. ISHIMARU H, Nakamoto K, Yamane M, Yamamoto T, et al
     Sweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice.
     J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00196.
     PubMed     Abstract available
     
     
     
389. HONG S, Maitra P, Kadoya K, Abdolvahabi A, et al
     Quantitative Confocal Raman Microspectroscopy to Evaluate Skin Penetration of Topically Applied Substances.
     J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00194.
     PubMed    
     
     
     
390. 
     WITHDRAWN: Expression of Concern: Zhou et al, Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis. J Invest Derm doi:10.1016/j.jid.2023.02.023.
     J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00173.
     PubMed     Abstract available
     
     
     
391. MARONESE CA, Costanzo A, Gilliet M, Marzano AV, et al
     Paradoxical Psoriasis: from its many faces to possible shared therapeutic targets.
     J Invest Dermatol. 2024 Mar 19:S0022-202X(24)00195.
     PubMed    
     
     
     
392. LI Q, Pang B, Dang E, Wang G, et al
     Endothelial Dysfunction in Psoriasis: An Integrative Review.
     J Invest Dermatol. 2024 Mar 15:S0022-202X(24)00171.
     PubMed     Abstract available
     
     
     
393. CHO SW, Malick H, Kim SJ, Grattoni A, et al
     Advances in Skin-on-a-Chip Technologies for Dermatological Disease Modeling.
     J Invest Dermatol. 2024 Mar 15:S0022-202X(24)00115.
     PubMed     Abstract available
     
     
     
394. BERNSTEIN R, Gaddameedhi S
     Time Is Running Out: The Circadian Clock Suggests Sex and Aging Differences in Human Epidermis.
     J Invest Dermatol. 2024 Mar 15:S0022-202X(24)00109.
     PubMed    
     
     
     
395. KAUR K, Ai R, Perry AG, Riley B, et al
     Skin cancer risk is increased by somatic mutations detected noninvasively in healthy-appearing sun-exposed skin.
     J Invest Dermatol. 2024 Mar 9:S0022-202X(24)00176.
     PubMed     Abstract available
     
     
     
396. CUI YZ, Xu F, Zhou Y, Wang ZY, et al
     SPRY1 deficiency in keratinocytes induces follicular melanocyte stem cells migration to epidermis through p53/SCF/C-KIT signaling.
     J Invest Dermatol. 2024 Mar 8:S0022-202X(24)00178.
     PubMed     Abstract available
     
     
     
397. BERNA-RICO E, Abbad-Jaime de Aragon C, Ballester-Martinez A, Perez-Bootello J, et al
     Monocyte-to-high-density lipoprotein ratio is associated with systemic inflammation, insulin resistance and coronary subclinical atherosclerosis in psoriasis: results from 2 observational cohorts.
     J Invest Dermatol. 2024 Mar 7:S0022-202X(24)00174.
     PubMed     Abstract available
     
     
     
398. MOHAMMED NBB, Lau LS, Souchak J, Qiu S, et al
     Tumor-intrinsic galectin-3 suppresses melanoma metastasis.
     J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00169.
     PubMed     Abstract available
     
     
     
399. DROLL SH, Zhang BJ, Levine MC, Xue C, et al
     CASZ1 is Essential for Skin Epidermal Terminal Differentiation.
     J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00172.
     PubMed     Abstract available
     
     
     
400. ROUSEL J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, et al
     Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
     J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168.
     PubMed    
     
     
     
401. DAS M, Mukherjee S, Geha RS
     Phosphodiesterase 4 Inhibitors, Basophils, and Atopic Dermatitis.
     J Invest Dermatol. 2024 Mar 3:S0022-202X(24)00096.
     PubMed    
     
     
     
402. BRAHIMI N, Piguet V
     Autophagy during Severe Acute Respiratory Syndrome Coronavirus 2 Induced Leukocytoclastic Vasculitis: New Insights.
     J Invest Dermatol. 2024;144:441-443.
     PubMed    
     
     
     
403. FLESHER JL, Fisher DE
     MAPK-Activating Gene Fusions in Congenital Nevi.
     J Invest Dermatol. 2024;144:446-448.
     PubMed    
     
     
     
404. GOLOB-SCHWARZL N, Pilic J, Benezeder T, Bordag N, et al
     Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.
     J Invest Dermatol. 2024;144:500-508.
     PubMed     Abstract available
     
     
     
405. WANG S, Wang R, Shang P, Zhu X, et al
     Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease.
     J Invest Dermatol. 2024;144:585-592.
     PubMed     Abstract available
     
     
     
406. BETTUZZI T, Hoisnard L, Beytout Q, Ingen-Housz-Oro S, et al
     Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.
     J Invest Dermatol. 2024;144:708-710.
     PubMed    
     
     
     
407. VALEI LOPES DE OLIVEIRA E, Tremeschin de Almeida Vieira F, de Souza Pinhel MA, Gripp AC, et al
     Differential FCGR2A and FCGR3A Alleles/Genotypes in Pemphigus Vulgaris and Pemphigus Foliaceus in Southeastern Brazil.
     J Invest Dermatol. 2024;144:702-705.
     PubMed    
     
     
     
408. BRITO S, Heo H, Cha B, Lee SH, et al
     The Slc45a4 Gene Regulates Pigmentation in a Manner Distinct from that of the OCA4 Gene Slc45a2.
     J Invest Dermatol. 2024;144:720-722.
     PubMed    
     
     
     
409. EZZEDINE K, Soliman AM, Li C, Camp HS, et al
     Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study.
     J Invest Dermatol. 2024;144:540-546.
     PubMed     Abstract available
     
     
     
410. WANG X, Mao D, Jia J, Zhang J, et al
     Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
     J Invest Dermatol. 2024;144:509-519.
     PubMed     Abstract available
     
     
     
411. BERTHY C, Gagnoux-Palacios L, Madrange M, Bodemer C, et al
     PRIMA-1(MET)/APR-246 Can Partially Rescue In Vitro Cell Adhesion of Patient-Derived Junctional Epidermolysis Bullosa Epidermal Cells.
     J Invest Dermatol. 2024;144:717-719.
     PubMed    
     
     
     
412. YU Z, Vieyra-Garcia P, Benezeder T, Crouch JD, et al
     Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.
     J Invest Dermatol. 2024;144:621-632.
     PubMed     Abstract available
     
     
     
413. ZRELSKI MM, Hosele S, Kustermann M, Fichtinger P, et al
     Plectin Deficiency in Fibroblasts Deranges Intermediate Filament and Organelle Morphology, Migration, and Adhesion.
     J Invest Dermatol. 2024;144:547-562.
     PubMed     Abstract available
     
     
     February 2024
414. LARSON EL, DeMeo DP, Young AB, Margevicius S, et al
     Circulating Monocytes are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.
     J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00166.
     PubMed     Abstract available
     
     
     
415. GALLO RL, Horswill AR
     Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis.
     J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00002.
     PubMed     Abstract available
     
     
     
416. STANDER S, Schmelz M
     Skin Innervation.
     J Invest Dermatol. 2024 Feb 24:S0022-202X(24)00085.
     PubMed     Abstract available
     
     
     
417. OLSEN CM, Pandeya N, Whiteman DC
     Trends in age at melanoma diagnosis according to thickness and histologic subtype have implications for causality and control.
     J Invest Dermatol. 2024 Feb 21:S0022-202X(24)00116.
     PubMed    
     
     
     
418. GRIT JL, Turner L, Essenburg CJ, Gallik KL, et al
     Ex-vivo patient-derived explant model for neurofibromatosis type 1-related cutaneous neurofibromas.
     J Invest Dermatol. 2024 Feb 21:S0022-202X(24)00117.
     PubMed     Abstract available
     
     
     
419. CHEN Q, Rong H, Zhang L, Wang Y, et al
     KLF2 Orchestrates Pathological Progression of Infantile Hemangioma through Hemangioma Stem Cell Fate Decisions.
     J Invest Dermatol. 2024 Feb 19:S0022-202X(24)00113.
     PubMed     Abstract available
     
     
     December 2023
420. NAKAI S, Kume M, Matsumura Y, Koguchi-Yoshioka H, et al
     CD69 is indispensable for the development of functional local immune memory in murine contact hypersensitivity.
     J Invest Dermatol. 2023 Dec 20:S0022-202X(23)03190.
     PubMed     Abstract available
     
     
     March 2023
421. SALAMITO M, Gillet B, Syx D, Vaganay E, et al
     NRF2 Shortage in Human Skin Fibroblasts Dysregulates Matrisome Gene Expression and Affects Collagen Fibrillogenesis.
     J Invest Dermatol. 2023;143:386-397.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.